Fluid delivery apparatus and method
-
0Associated
Cases -
0Associated
Defendants -
0Accused
Products -
335Forward
Citations -
0
Petitions -
3
Assignments
First Claim
1. An apparatus for delivering a fluid, said apparatus comprising:
- a housing;
a displaceable membrane disposed within said housing, dividing a portion of said housing into a first chamber and a second chamber, said first chamber formed in part, of said housing, said first chamber for containing fluid for delivery and having a port in fluid communication with said first chamber, and said second chamber for containing a driving gas, said displaceable membrane being impermeable to the driving gas;
a pump for pressurizing driving gas in said second chamber, thereby exerting a force on said displaceable membrane, thus expelling fluid contained within said first member from said port, said pump comprising an electrochemical gas generation cell; and
means for delivering fluid from said port to a desired location.
3 Assignments
0 Petitions

Accused Products

Abstract
An apparatus (120) useful for, among other things, subcutaneous drug delivery includes a housing (124), a fluid reservoir (154) disposed within the housing for storing the fluid, a pump or pressurized chamber for pressurizing a driving gas and exerting a force on the fluid reservoir to expel the fluid reservoir'"'"'s contents, and a needle (150) or absorbent pad fluidically communicating with the reservoir. The apparatus may further include a pump activation mechanism such as a button and an electrical circuit such that pushing the button activates a circuit and connects a battery (138) to a pump (126), and a pump control mechanism such as electrical circuitry to control the voltage gradient to a pump to control fluid delivery.
404 Citations
Dual Drug Delivery Device | ||
Patent #
US 20110034872A1
Filed 12/08/2008
|
Current Assignee
University of Michigan
|
Sponsoring Entity
University of Michigan
|
Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method | ||
Patent #
US 7,896,867 B2
Filed 07/01/2005
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Template system for multi-reservoir implantable pump | ||
Patent #
US 7,914,510 B2
Filed 03/02/2010
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Multi-cartridge fluid delivery device | ||
Patent #
US 7,914,499 B2
Filed 03/28/2007
|
Current Assignee
Valeritas LLC
|
Sponsoring Entity
Valeritas LLC
|
Injection device for administering a vaccine | ||
Patent #
US 7,896,841 B2
Filed 02/17/2005
|
Current Assignee
Childrens Hospital Medical Center
|
Sponsoring Entity
Childrens Hospital Medical Center
|
Flow condition sensor assembly for patient infusion device | ||
Patent #
US 7,887,505 B2
Filed 10/08/2003
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
WOUND CLEANSING APPARATUS IN-SITU | ||
Patent #
US 20110054423A1
Filed 11/05/2010
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Safety mechanism to prevent accidental patient injection and methods of same | ||
Patent #
US 7,887,506 B1
Filed 11/21/2000
|
Current Assignee
FELTON INTERNATIONAL INC. NKA PULSE NEEDLEFREE SYSTEMS INC.
|
Sponsoring Entity
FELTON INTERNATIONAL INC. NKA PULSE NEEDLEFREE SYSTEMS INC.
|
Wound cleansing apparatus in-situ | ||
Patent #
US 7,964,766 B2
Filed 10/28/2004
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Drug delivery system for treating erectile dysfunction | ||
Patent #
US 20110137114A1
Filed 11/15/2010
|
Current Assignee
Douglas Robert Matthew, Schwartz Matthew Zane
|
Sponsoring Entity
Douglas Robert Matthew, Schwartz Matthew Zane
|
WOUND CLEANSING APPARATUS IN-SITU | ||
Patent #
US 20110087179A2
Filed 08/02/2010
|
Current Assignee
Derek Nicolini, Julian Lee-Webb, Bryan Greener, Blott Patrick, Hartwell Edward
|
Sponsoring Entity
Derek Nicolini, Julian Lee-Webb, Bryan Greener, Blott Patrick, Hartwell Edward
|
Drug delivery device | ||
Patent #
US 7,998,117 B2
Filed 05/15/2008
|
Current Assignee
Alkermes Pharma Ireland Limited
|
Sponsoring Entity
Alkermes Pharma Ireland Limited
|
GAS-PRESSURED MEDICATION DELIVERY DEVICE | ||
Patent #
US 20110238037A1
Filed 03/18/2011
|
Current Assignee
Halozyme Inc.
|
Sponsoring Entity
Halozyme Inc.
|
OSMOTIC PUMP APPARATUS AND ASSOCIATED METHODS | ||
Patent #
US 20110184389A1
Filed 03/31/2011
|
Current Assignee
Medtronic Incorporated
|
Sponsoring Entity
Medtronic Incorporated
|
Electrochemical wound therapy device | ||
Patent #
US 8,012,169 B2
Filed 12/17/2007
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Bladder Arrangement For Microneedle-Based Drug Delivery Device | ||
Patent #
US 20110172601A1
Filed 01/08/2010
|
Current Assignee
Wisconsin Alumni Research Foundation
|
Sponsoring Entity
Wisconsin Alumni Research Foundation
|
System of stepped flow rate regulation using compressible members | ||
Patent #
US 8,056,582 B2
Filed 08/08/2008
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Multi-reservoir implantable pump with patient controlled actuation | ||
Patent #
US 8,034,029 B2
Filed 05/25/2005
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Multi-reservoir implantable pump with variable flow rate capabilities | ||
Patent #
US 8,034,030 B2
Filed 05/25/2005
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Apparatus and method for rapid auto-injection of medication | ||
Patent #
US 7,658,724 B2
Filed 03/24/2005
|
Current Assignee
Seedings Life Science Ventures LLC
|
Sponsoring Entity
Seedings Life Science Ventures LLC
|
METHOD OF ANALYZING AN ANALYTE | ||
Patent #
US 20100210932A1
Filed 12/21/2007
|
Current Assignee
Bayer Healthcare LLC
|
Sponsoring Entity
Bayer Healthcare LLC
|
Fluid medication delivery device | ||
Patent #
US 7,771,413 B2
Filed 09/16/2004
|
Current Assignee
Avent Incorporated
|
Sponsoring Entity
Kimberly-Clark Worldwide Incorporated
|
Device and method for wound therapy | ||
Patent #
US 7,779,625 B2
Filed 12/13/2006
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Kalypto Medical Inc.
|
Impedance sensor | ||
Patent #
US 7,645,263 B2
Filed 10/21/2002
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
MEDICAMENT DELIVERY APPARATUS | ||
Patent #
US 20100063486A1
Filed 09/20/2007
|
Current Assignee
Progenity Inc.
|
Sponsoring Entity
Progenity Inc.
|
BIOSYNCHRONOUS TRANSDERMAL DRUG DELIVERY | ||
Patent #
US 20100280432A1
Filed 07/13/2010
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
SYSTEM OF STEPPED FLOW RATE REGULATION USING COMPRESSIBLE MEMBERS | ||
Patent #
US 20100032041A1
Filed 08/08/2008
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Microneedle transport device | ||
Patent #
US 7,651,475 B2
Filed 01/11/2008
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
WOUND CLEANSING APPARATUS IN-SITU | ||
Patent #
US 20100298793A1
Filed 08/02/2010
|
Current Assignee
Derek Nicolini, Edward Yerbury Hartwell, Patrick Lewis Blott, Julian Lee-Webb, Bryan Greener
|
Sponsoring Entity
Derek Nicolini, Edward Yerbury Hartwell, Patrick Lewis Blott, Julian Lee-Webb, Bryan Greener
|
Biosynchronous transdermal drug delivery | ||
Patent #
US 7,780,981 B2
Filed 09/13/2005
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
GREETING CARD FRAGRANCE DELIVERY SYSTEM | ||
Patent #
US 20100176214A1
Filed 01/12/2010
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
VARIABLE FLOW INFUSION PUMP SYSTEM | ||
Patent #
US 20100069892A1
Filed 11/19/2009
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
Aqulinx Medical Inc.
|
FLUID DELIVERY DEVICE WITH A DIFFUSION MEMBRANE FOR FAST RESPONSE TIME | ||
Patent #
US 20100222770A1
Filed 03/11/2010
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Electrochemical dispenser | ||
Patent #
US 7,681,809 B2
Filed 06/12/2008
|
Current Assignee
MR CONSULTING SERVICES
|
Sponsoring Entity
MR CONSULTING SERVICES
|
Fluid medication delivery device | ||
Patent #
US 7,854,732 B2
Filed 12/23/2008
|
Current Assignee
Avent Incorporated
|
Sponsoring Entity
Kimberly-Clark Worldwide Incorporated
|
Injection device for administering a vaccine | ||
Patent #
US 7,670,314 B2
Filed 02/17/2005
|
Current Assignee
Childrens Hospital Medical Center
|
Sponsoring Entity
Childrens Hospital Medical Center
|
Sensing and interactive drug delivery | ||
Patent #
US 20100049172A1
Filed 06/29/2009
|
Current Assignee
Chance Britton
|
Sponsoring Entity
Chance Britton
|
SLIDEABLE FLOW METERING DEVICES AND RELATED METHODS | ||
Patent #
US 20100065579A1
Filed 02/26/2009
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Template system for multi-reservoir implantable pump | ||
Patent #
US 7,708,730 B2
Filed 01/30/2006
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
TEMPLATE SYSTEM FOR MULTI-RESERVOIR IMPLANTABLE PUMP | ||
Patent #
US 20100160859A1
Filed 03/02/2010
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
Aqulinx Medical Inc.
|
MEDICAL DEVICE FOR PLACEMENT ON THE SKIN OF A PATIENT | ||
Patent #
US 20090012473A1
Filed 07/09/2008
|
Current Assignee
Roche Diagnostics International AG
|
Sponsoring Entity
Roche Diagnostics International AG
|
Brachytherapy apparatus and method for treating a target tissue through an external surface of the tissue | ||
Patent #
US 7,494,457 B2
Filed 11/07/2003
|
Current Assignee
Cytyc Corporation
|
Sponsoring Entity
Cytyc Corporation
|
Systems and methods for metered delivery of medication using stored energy | ||
Patent #
US 20090062747A1
Filed 08/29/2007
|
Current Assignee
Calibra Medical Inc.
|
Sponsoring Entity
Calibra Medical Inc.
|
Drug eluting brachytherapy methods and apparatus | ||
Patent #
US 7,524,275 B2
Filed 11/14/2003
|
Current Assignee
Cytyc Corporation
|
Sponsoring Entity
Cytyc Corporation
|
Tissue positioning systems and methods for use with radiation therapy | ||
Patent #
US 7,524,274 B2
Filed 11/07/2003
|
Current Assignee
Cytyc Corporation
|
Sponsoring Entity
Cytyc Corporation
|
FLUID MEDICATION DELIVERY DEVICE | ||
Patent #
US 20090105667A1
Filed 12/23/2008
|
Current Assignee
Avent Incorporated
|
Sponsoring Entity
Avent Incorporated
|
Hydraulically actuated pump for long duration medicament administration | ||
Patent #
US 7,530,968 B2
Filed 04/23/2004
|
Current Assignee
Valeritas Inc.
|
Sponsoring Entity
Valeritas Inc.
|
Electrochemical Negative Pressure Wound Therapy Device | ||
Patent #
US 20090131888A1
Filed 12/17/2007
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
TWO CHAMBER PUMPS AND RELATED METHODS | ||
Patent #
US 20090191067A1
Filed 01/25/2008
|
Current Assignee
TANDEM CARE DIABETS INC.
|
Sponsoring Entity
TANDEM CARE DIABETS INC.
|
AUTO-REPLENISHING, WOUND-DRESSING APPARATUS AND METHOD | ||
Patent #
US 20090216204A1
Filed 12/22/2008
|
Current Assignee
Aplion Medical LLC
|
Sponsoring Entity
Aplion Medical LLC
|
Device and method for wound therapy | ||
Patent #
US 7,615,036 B2
Filed 05/11/2006
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Kalypto Medical Inc.
|
Device employing gas generating cell for facilitating controlled release of fluid into ambient environment | ||
Patent #
US 7,614,568 B2
Filed 06/14/2004
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Variable flow infusion pump system | ||
Patent #
US 7,637,892 B2
Filed 11/17/2006
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Method and device for painless injection of medication | ||
Patent #
US 7,637,891 B2
Filed 09/12/2003
|
Current Assignee
Childrens Hospital Medical Center
|
Sponsoring Entity
Childrens Hospital Medical Center
|
Infusion pump and method for use | ||
Patent #
US 7,341,581 B2
Filed 01/27/2006
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Reusable Fluid Dispenser | ||
Patent #
US 20080060879A1
Filed 07/07/2004
|
Current Assignee
A.T.S. Electro-Lube Holdings Ltd.
|
Sponsoring Entity
A.T.S. Electro-Lube Holdings Ltd.
|
Microneedle transdermal transport device | ||
Patent #
US 7,364,568 B2
Filed 10/21/2002
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
Implantable radiotherapy/brachytherapy radiation detecting apparatus and methods | ||
Patent #
US 7,354,391 B2
Filed 11/07/2003
|
Current Assignee
Cytyc Corporation
|
Sponsoring Entity
Cytyc Corporation
|
Device and method for wound therapy | ||
Patent #
US 7,361,184 B2
Filed 09/08/2003
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
SYSTEM AND METHOD FOR REDUCING PHOTON SCATTER IN DERMAL TISSUE | ||
Patent #
US 20080114340A1
Filed 11/01/2006
|
Current Assignee
BioTex Incorporated
|
Sponsoring Entity
-
|
Osmotic pump apparatus and associated methods | ||
Patent #
US 20080102119A1
Filed 11/01/2006
|
Current Assignee
Medtronic Incorporated
|
Sponsoring Entity
Medtronic Incorporated
|
Infusion pump and method for use | ||
Patent #
US 7,374,556 B2
Filed 01/31/2006
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Drug delivery device | ||
Patent #
US 7,384,413 B2
Filed 06/13/2003
|
Current Assignee
Alkermes Pharma Ireland Limited
|
Sponsoring Entity
Elan Pharma International Limited
|
Method of therapeutic drug monitoring | ||
Patent #
US 20080152592A1
Filed 12/06/2007
|
Current Assignee
Ascensia Diabetes Care Holdings AG
|
Sponsoring Entity
-
|
Electrochemical Wound Therapy Device | ||
Patent #
US 20080183119A1
Filed 12/17/2007
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Capillary-Action Wound Therapy Device | ||
Patent #
US 20080188820A1
Filed 12/17/2007
|
Current Assignee
Ashok V. Joshi
|
Sponsoring Entity
-
|
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like | ||
Patent #
US 20080220092A1
Filed 10/31/2007
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
DRUG DELIVERY DEVICE | ||
Patent #
US 20080215005A1
Filed 05/15/2008
|
Current Assignee
Alkermes Pharma Ireland Limited
|
Sponsoring Entity
Alkermes Pharma Ireland Limited
|
Microneedle transport device | ||
Patent #
US 7,429,258 B2
Filed 09/09/2002
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
Gas Generation Dispenser Apparatus and Method for On-Demand Fluid Delivery | ||
Patent #
US 20080257915A1
Filed 10/24/2007
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Microneedle transdermal transport device | ||
Patent #
US 20080281273A1
Filed 04/29/2008
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
Fluid medication delivery device | ||
Patent #
US 7,470,266 B2
Filed 09/16/2003
|
Current Assignee
Avent Incorporated
|
Sponsoring Entity
I-Flow Corporation
|
Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method | ||
Patent #
US 7,458,965 B2
Filed 05/26/2005
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
MICRONEEDLE TRANSPORT DEVICE | ||
Patent #
US 20080319392A1
Filed 01/11/2008
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
ELECTROCHEMICAL DISPENSER | ||
Patent #
US 20080308647A1
Filed 06/12/2008
|
Current Assignee
MR CONSULTING SERVICES
|
Sponsoring Entity
MR CONSULTING SERVICES
|
Fluid delivery device having an electrochemical pump with an anionic exchange membrane and associated method | ||
Patent #
US 7,470,267 B2
Filed 05/01/2002
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
DEVICE EMPLOYING GAS GENERATING CELL FOR FACILITATING CONTROLLED RELEASE OF FLUID INTO AMBIENT ENVIRONMENT | ||
Patent #
US 20070001024A1
Filed 07/01/2005
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Implantable pump with infinitely variable resistor | ||
Patent #
US 20070005044A1
Filed 06/21/2005
|
Current Assignee
PALYON MEDICAL BVI LIMITED
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Regulator | ||
Patent #
US 20070129678A1
Filed 12/06/2005
|
Current Assignee
Medtronic Incorporated
|
Sponsoring Entity
Medtronic Incorporated
|
Flexible bag for fluent material dispenser | ||
Patent #
US 7,237,691 B2
Filed 12/19/2005
|
Current Assignee
Baxter International Inc.
|
Sponsoring Entity
Baxter International Inc.
|
Template system for multi-reservoir implantable pump | ||
Patent #
US 20070185470A1
Filed 01/30/2006
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
Aqulinx Medical Inc.
|
BIOSYNCHRONOUS TRANSDERMAL DRUG DELIVERY | ||
Patent #
US 20070191815A1
Filed 09/13/2005
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
DEVICE AND METHOD FOR WOUND THERAPY | ||
Patent #
US 20070265586A1
Filed 12/13/2006
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Smith Nephew Inc.
|
Device and method for wound therapy | ||
Patent #
US 20070265585A1
Filed 05/11/2006
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Smith Nephew Inc.
|
Injection Device for Administering a Vaccine | ||
Patent #
US 20070276320A1
Filed 02/17/2005
|
Current Assignee
Childrens Hospital Medical Center
|
Sponsoring Entity
Childrens Hospital Medical Center
|
Infusion device pump | ||
Patent #
US 20070299408A1
Filed 02/12/2007
|
Current Assignee
Calibra Medical Inc.
|
Sponsoring Entity
Calibra Medical Inc.
|
Infusion device with dosage dial control | ||
Patent #
US 20070299399A1
Filed 02/12/2007
|
Current Assignee
Calibra Medical Inc.
|
Sponsoring Entity
Calibra Medical Inc.
|
Transcutaneous fluid delivery system | ||
Patent #
US 7,303,549 B2
Filed 03/21/2005
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Infusion device capable of providing multiple liquid medicaments | ||
Patent #
US 20070299398A1
Filed 02/12/2007
|
Current Assignee
Calibra Medical Inc.
|
Sponsoring Entity
Calibra Medical Inc.
|
FLOW RESTRICTION SYSTEM AND METHOD FOR PATIENT INFUSION DEVICE | ||
Patent #
US 20060041229A1
Filed 10/11/2005
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Sensing and interactive drug delivery | ||
Patent #
US 20060030813A1
Filed 09/24/2005
|
Current Assignee
Chance Britton
|
Sponsoring Entity
Chance Britton
|
FLUID DELIVERY DEVICE HAVING AN ELECTROCHEMICAL PUMP WITH AN ION-EXCHANGE MEMBRANE AND ASSOCIATED METHOD | ||
Patent #
US 20060052768A1
Filed 05/26/2005
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Infusion pump and method for use | ||
Patent #
US 7,008,403 B1
Filed 07/19/2002
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
PHLUID INC.
|
Flow restriction system and method for patient infusion device | ||
Patent #
US 7,018,360 B2
Filed 07/16/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Liquid dispenser and flexible bag therefor | ||
Patent #
US 7,007,824 B2
Filed 08/14/2003
|
Current Assignee
Baxter International Inc.
|
Sponsoring Entity
Baxter International Inc.
|
Devices, systems and methods for patient infusion | ||
Patent #
US 7,029,455 B2
Filed 11/15/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Drug containment system | ||
Patent #
US 7,025,754 B2
Filed 07/01/2002
|
Current Assignee
Battelle Memorial Institute
|
Sponsoring Entity
VENTAIRA PHARMACEUTICALS INC.
|
Electro-osmotic fluid delivery device and method | ||
Patent #
US 20060116663A1
Filed 07/01/2005
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Oscillator and charge pump circuit using the same | ||
Patent #
US 20060132247A1
Filed 12/20/2005
|
Current Assignee
Renesas Electronics Corporation
|
Sponsoring Entity
Renesas Electronics Corporation
|
Transdermal transport device with suction | ||
Patent #
US 7,066,922 B2
Filed 10/21/2002
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
Cell culture media dispenser | ||
Patent #
US 20060134598A1
Filed 12/20/2004
|
Current Assignee
DRUMMOND SCIENTIFIC COMPANY
|
Sponsoring Entity
DRUMMOND SCIENTIFIC COMPANY
|
FLUID DELIVERY DEVICE HAVING AN ELECTROCHEMICAL PUMP WITH AN ION-EXCHANGE MEMBRANE AND ASSOCIATED METHOD | ||
Patent #
US 20060116641A1
Filed 07/01/2005
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Infusion pump and method for use | ||
Patent #
US 20060150748A1
Filed 01/31/2006
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Infusion pump and method for use | ||
Patent #
US 20060150747A1
Filed 01/27/2006
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
CHASSIS FOR FLUID DELIVERY DEVICE | ||
Patent #
US 20060178633A1
Filed 03/28/2005
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Components and methods for patient infusion device | ||
Patent #
US 7,128,727 B2
Filed 09/30/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Induction of mucosal immunity by vaccination via the skin route | ||
Patent #
US 20060228375A1
Filed 06/16/2006
|
Current Assignee
PowderJect Vaccines Inc.
|
Sponsoring Entity
PowderJect Vaccines Inc.
|
Multi-reservoir implantable pump with variable flow rate capabilities | ||
Patent #
US 20060271022A1
Filed 05/25/2005
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
Aqulinx Medical Inc.
|
Devices, systems and methods for patient infusion | ||
Patent #
US 7,137,964 B2
Filed 10/28/2003
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Multi-reservoir implantable pump with patient controlled actuation | ||
Patent #
US 20060271021A1
Filed 05/25/2005
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
Aqulinx Medical Inc.
|
UNIVERSAL PROTECTOR CAP WITH AUTO-DISABLE FEATURES FOR NEEDLE-FREE INJECTORS | ||
Patent #
US 20060287631A1
Filed 05/23/2006
|
Current Assignee
PULSE NEEDLEFREE SYSTEMS INC.
|
Sponsoring Entity
PULSE NEEDLEFREE SYSTEMS INC.
|
Dispenser components and methods for patient infusion device | ||
Patent #
US 7,144,384 B2
Filed 09/30/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Pre-filled drug-delivery device and method of manufacture and assembly of same | ||
Patent #
US 6,843,782 B2
Filed 04/18/2001
|
Current Assignee
Elan Pharma International Limited
|
Sponsoring Entity
Elan Pharma International Limited
|
Laminated patient infusion device | ||
Patent #
US 20050021005A1
Filed 11/04/2003
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Dispenser and pressure/vacuum converting machine | ||
Patent #
US 20050011908A1
Filed 07/16/2003
|
Current Assignee
Baxter International Inc.
|
Sponsoring Entity
Baxter International Inc.
|
Fluid medication delivery device | ||
Patent #
US 20050058711A1
Filed 09/16/2003
|
Current Assignee
Avent Incorporated
|
Sponsoring Entity
Avent Incorporated
|
Device and method for wound therapy | ||
Patent #
US 20050070835A1
Filed 09/08/2003
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Rapid-exchange balloon catheter with hypotube shaft | ||
Patent #
US 20050070847A1
Filed 09/29/2003
|
Current Assignee
Cordis Corporation
|
Sponsoring Entity
Cordis Corporation
|
Method for advising patients concerning doses of insulin | ||
Patent #
US 20050065760A1
Filed 09/23/2003
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Signal device with electro-muscle stimulation feature | ||
Patent #
US 20050075670A1
Filed 10/06/2003
|
Current Assignee
Novo Nordisk AS
|
Sponsoring Entity
Novo Nordisk AS
|
Brachytherapy apparatus and method for treating a target tissue through an external surface of the tissue | ||
Patent #
US 20050101825A1
Filed 11/07/2003
|
Current Assignee
Cytyc Corporation
|
Sponsoring Entity
Cytyc Corporation
|
Fluid medication delivery device | ||
Patent #
US 20050106225A1
Filed 09/16/2004
|
Current Assignee
Avent Incorporated
|
Sponsoring Entity
Avent Incorporated
|
Tissue positioning systems and methods for use with radiation therapy | ||
Patent #
US 20050101860A1
Filed 11/07/2003
|
Current Assignee
Cytyc Corporation
|
Sponsoring Entity
Cytyc Corporation
|
Pump having flexible liner and compounding apparatus having such a pump | ||
Patent #
US 6,905,314 B2
Filed 10/16/2001
|
Current Assignee
Baxter International Inc.
|
Sponsoring Entity
Baxter International Inc.
|
Method For Visual Output Verification | ||
Patent #
US 20050182366A1
Filed 04/27/2005
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Apparatus and method for rapid auto-injection of medication | ||
Patent #
US 20050171477A1
Filed 03/24/2005
|
Current Assignee
Seedlings Life Science Ventures
|
Sponsoring Entity
Seedlings Life Science Ventures
|
DEVICES, SYSTEMS AND METHODS FOR PATIENT INFUSION | ||
Patent #
US 20050171512A1
Filed 12/07/2004
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Sensing and interactive drug delivery | ||
Patent #
US 6,949,081 B1
Filed 08/26/1999
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NON-INVASIVE TECHNOLOGY INC.
|
FLUID DELIVERY DEVICE | ||
Patent #
US 20050238507A1
Filed 03/28/2005
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
TRANSDERMAL DRUG DELIVERY METHOD AND SYSTEM | ||
Patent #
US 20050238704A1
Filed 09/15/2004
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Transcutaneous fluid delivery system | ||
Patent #
US 6,960,192 B1
Filed 04/23/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Apparatus and method for rapid auto-injection of medication | ||
Patent #
US 6,979,316 B1
Filed 05/23/2002
|
Current Assignee
Seedlings Life Science Ventures LLC
|
Sponsoring Entity
Seedlings Life Science Ventures LLC
|
Flow restriction system and method for patient infusion device | ||
Patent #
US 20040015131A1
Filed 07/16/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Drug containment system | ||
Patent #
US 20040001655A1
Filed 07/01/2002
|
Current Assignee
Battelle Memorial Institute
|
Sponsoring Entity
Battelle Memorial Institute
|
Motor control device | ||
Patent #
US 20040027083A1
Filed 04/25/2003
|
Current Assignee
Toyoda Koki Kabushiki Kaisha
|
Sponsoring Entity
Toyoda Koki Kabushiki Kaisha
|
Flow condition sensor assembly for patient infusion device | ||
Patent #
US 6,692,457 B2
Filed 03/01/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Transcutaneous delivery means | ||
Patent #
US 6,699,218 B2
Filed 11/09/2001
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Components and methods for patient infusion device | ||
Patent #
US 20040064096A1
Filed 09/30/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Plunger assembly for patient infusion device | ||
Patent #
US 6,723,072 B2
Filed 06/06/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Plunger assembly for patient infusion device | ||
Patent #
US 20040078028A1
Filed 09/15/2003
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Dispenser components and methods for patient infusion device | ||
Patent #
US 20040064088A1
Filed 09/30/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Flow control apparatus for use in dispensing fluent material | ||
Patent #
US 20040094573A1
Filed 11/12/2003
|
Current Assignee
Baxter International Inc.
|
Sponsoring Entity
Baxter International Inc.
|
Transcutaneous delivery means | ||
Patent #
US 20040092865A1
Filed 10/08/2003
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Devices, systems and methods for patient infusion | ||
Patent #
US 20040087894A1
Filed 10/28/2003
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Modular infusion device and method | ||
Patent #
US 6,749,587 B2
Filed 02/22/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Skin attachment apparatus and method for patient infusion device | ||
Patent #
US 20040116866A1
Filed 12/17/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Induction of mucosal immunity by vaccination via the skin route | ||
Patent #
US 20040109874A1
Filed 12/02/2003
|
Current Assignee
PowderJect Vaccines Inc.
|
Sponsoring Entity
PowderJect Vaccines Inc.
|
METHOD AND DEVICE FOR PAINLESS INJECTION OF MEDICATION | ||
Patent #
US 20040116847A1
Filed 09/12/2003
|
Current Assignee
Childrens Hospital Medical Center
|
Sponsoring Entity
Childrens Hospital Medical Center
|
Flow condition sensor assembly for patient infusion device | ||
Patent #
US 20040127844A1
Filed 10/08/2003
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Liquid dispenser and flexible bag therefor | ||
Patent #
US 20040144799A1
Filed 01/24/2003
|
Current Assignee
Baxter International Inc.
|
Sponsoring Entity
Baxter International Inc.
|
Medical apparatus remote control and method | ||
Patent #
US 6,768,425 B2
Filed 12/21/2001
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Dispenser for patient infusion device | ||
Patent #
US 20040153032A1
Filed 11/07/2003
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
-
|
Apparatus, method and flexible bag for use in manufacturing | ||
Patent #
US 6,769,231 B2
Filed 07/19/2001
|
Current Assignee
Baxter International Inc.
|
Sponsoring Entity
Baxter International Inc.
|
Injector assembly with driving means and locking means | ||
Patent #
US 6,770,054 B1
Filed 11/21/2000
|
Current Assignee
FELTON INTERNATIONAL INC. NKA PULSE NEEDLEFREE SYSTEMS INC.
|
Sponsoring Entity
FELTON INTERNATIONAL INC.
|
Universal anti-infectious protector for needleless injectors | ||
Patent #
US 6,802,826 B1
Filed 10/10/2000
|
Current Assignee
FELTON INTERNATIONAL INC. NKA PULSE NEEDLEFREE SYSTEMS INC.
|
Sponsoring Entity
FELTON INTERNATIONAL INC.
|
Pre-filled drug-delivery device and method of manufacture and assembly of same | ||
Patent #
US 6,824,529 B2
Filed 04/17/2001
|
Current Assignee
Elan Pharma International Limited
|
Sponsoring Entity
Elan Pharma International Limited
|
Flow condition sensor assembly for patient infusion device | ||
Patent #
US 6,830,558 B2
Filed 03/01/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Microbolus infusion pump | ||
Patent #
US 6,554,822 B1
Filed 04/28/2000
|
Current Assignee
Regents of the University of California
|
Sponsoring Entity
Regents of the University of California
|
Impedance sensor | ||
Patent #
US 20030083641A1
Filed 10/21/2002
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
Microneedle transdermal transport device | ||
Patent #
US 20030083619A1
Filed 10/21/2002
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
Transdermal transport device with an electrolytic actuator | ||
Patent #
US 20030083618A1
Filed 10/21/2002
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
Microneedle transport device | ||
Patent #
US 20030083645A1
Filed 09/09/2002
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
Transdermal transport device with suction | ||
Patent #
US 20030139727A1
Filed 10/21/2002
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
Drug delivery device | ||
Patent #
US 6,595,956 B1
Filed 03/23/1999
|
Current Assignee
Alkermes Pharma Ireland Limited
|
Sponsoring Entity
Elan Pharma International Limited
|
Externally-controllable constant-flow medication delivery system | ||
Patent #
US 6,589,205 B1
Filed 11/16/2000
|
Current Assignee
Medallion Therapeutics Inc.
|
Sponsoring Entity
Advanced Bionics Corporation
|
Method and apparatus for removing cap from medical device | ||
Patent #
US 6,626,871 B1
Filed 10/10/2000
|
Current Assignee
FELTON INTERNATIONAL INC. NKA PULSE NEEDLEFREE SYSTEMS INC.
|
Sponsoring Entity
FELTON INTERNATIONAL INC.
|
Dispenser for patient infusion device | ||
Patent #
US 6,656,159 B2
Filed 04/23/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Dispenser for patient infusion device | ||
Patent #
US 6,656,158 B2
Filed 04/23/2002
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Laminated patient infusion device | ||
Patent #
US 6,669,669 B2
Filed 10/12/2001
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Device for measuring volume of drug | ||
Patent #
US 20030236498A1
Filed 06/13/2003
|
Current Assignee
Alkermes Pharma Ireland Limited
|
Sponsoring Entity
-
|
Method and apparatus for drug infusion | ||
Patent #
US 6,394,981 B2
Filed 10/11/1999
|
Current Assignee
Medtronic Incorporated
|
Sponsoring Entity
Medtronic Incorporated
|
Interstitial brachytherapy apparatus and method for treatment of proliferative tissue diseases | ||
Patent #
US 6,413,204 B1
Filed 04/15/1999
|
Current Assignee
Cytyc Corporation
|
Sponsoring Entity
PROXIMA THERAPEUTICS INC.
|
External gas powered programmable infusion device | ||
Patent #
US 6,458,102 B1
Filed 05/25/2000
|
Current Assignee
Medtronic Minimed Incorporated
|
Sponsoring Entity
Medtronic Minimed Incorporated
|
Device and method for infusion of small molecule insulin mimetic materials | ||
Patent #
US 6,461,331 B1
Filed 05/08/2000
|
Current Assignee
Medtronic Minimed Incorporated
|
Sponsoring Entity
Medtronic Minimed Incorporated
|
Disposable infusion device | ||
Patent #
US 6,485,461 B1
Filed 04/04/2000
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Pre-filled drug-delivery device and method of manufacture and assembly of same | ||
Patent #
US 6,500,150 B1
Filed 06/23/1998
|
Current Assignee
Elan Pharma International Limited
|
Sponsoring Entity
ELAN MEDICAL TECHNOLOGIES LTD.
|
Subcutaneous drug delivery device with improved filling system | ||
Patent #
US 6,186,982 B1
Filed 05/05/1998
|
Current Assignee
Alkermes Pharma Ireland Limited
|
Sponsoring Entity
Elan Corporation PLC
|
Constant flow medication infusion pump | ||
Patent #
US 6,280,416 B1
Filed 02/19/1999
|
Current Assignee
MINIMED INC.
|
Sponsoring Entity
MINIMED INC.
|
Negative pressure pump | ||
Patent #
US 6,283,943 B1
Filed 02/19/1999
|
Current Assignee
MINIMED INC.
|
Sponsoring Entity
MINIMED INC.
|
Double-wall balloon catheter for treatment of proliferative tissue | ||
Patent #
US 5,913,813 A
Filed 07/24/1997
|
Current Assignee
Cytyc Corporation
|
Sponsoring Entity
PROXIMA THERAPEUTICS INC.
|
Low-profile automatic injection device with self-emptying reservoir | ||
Patent #
US 5,957,895 A
Filed 02/20/1998
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
-
|
Gas generating device for delivering beneficial agents to a body cavity | ||
Patent #
US 5,951,538 A
Filed 08/07/1997
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
-
|
Injection Device for Administering a Vaccine | ||
Patent #
US 20070293826A1
Filed 02/17/2005
|
Current Assignee
Childrens Hospital Medical Center
|
Sponsoring Entity
Childrens Hospital Medical Center
|
Infusion device with pressurizable liquid medicament chamber | ||
Patent #
US 20070299397A1
Filed 02/12/2007
|
Current Assignee
Calibra Medical Inc.
|
Sponsoring Entity
Calibra Medical Inc.
|
Infusion device with piston pump | ||
Patent #
US 20070299401A1
Filed 02/12/2007
|
Current Assignee
Calibra Medical Inc.
|
Sponsoring Entity
Calibra Medical Inc.
|
Infusion device with dome pump | ||
Patent #
US 20070299400A1
Filed 02/12/2007
|
Current Assignee
Calibra Medical Inc.
|
Sponsoring Entity
Calibra Medical Inc.
|
Infusion device with piston pump | ||
Patent #
US 8,114,064 B2
Filed 02/12/2007
|
Current Assignee
Calibra Medical Inc.
|
Sponsoring Entity
Calibra Medical Inc.
|
Wound cleansing apparatus in-situ | ||
Patent #
US 8,080,702 B2
Filed 08/02/2010
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Hydraulically actuated pump for long duration medicament administration | ||
Patent #
US 8,070,726 B2
Filed 12/16/2008
|
Current Assignee
Valeritas Inc.
|
Sponsoring Entity
Valeritas Inc.
|
Implantable pump with infinitely variable resistor | ||
Patent #
US 8,114,055 B2
Filed 05/10/2005
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Gas generation dispenser apparatus and method for on-demand fluid delivery | ||
Patent #
US 8,113,390 B2
Filed 10/24/2007
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Reduced pressure treatment system | ||
Patent #
US 8,118,794 B2
Filed 11/02/2010
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Bluesky Medical Group Inc.
|
Variable flow infusion pump system | ||
Patent #
US 8,177,750 B2
Filed 11/19/2009
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Reduced size implantable pump | ||
Patent #
US 8,211,060 B2
Filed 05/10/2005
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
VISUAL INDICATOR AND FLUID DISPENSER | ||
Patent #
US 20120191051A1
Filed 08/20/2010
|
Current Assignee
Preciflex Sa
|
Sponsoring Entity
Preciflex Sa
|
Fluid medication delivery device | ||
Patent #
US 8,241,269 B2
Filed 08/10/2010
|
Current Assignee
Avent Incorporated
|
Sponsoring Entity
Kimberly-Clark Worldwide Incorporated
|
Microneedle transdermal transport device | ||
Patent #
US 8,246,582 B2
Filed 04/29/2008
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like | ||
Patent #
US 8,252,321 B2
Filed 10/31/2007
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Reduced pressure wound treatment system | ||
Patent #
US 8,282,611 B2
Filed 03/17/2010
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Bluesky Medical Group Inc.
|
Remote-controlled drug pump devices | ||
Patent #
US 8,285,328 B2
Filed 04/20/2011
|
Current Assignee
MiniPumps LLC
|
Sponsoring Entity
MiniPumps LLC
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,287,495 B2
Filed 10/10/2011
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,298,184 B2
Filed 10/11/2011
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Reduced pressure wound treatment system | ||
Patent #
US 8,303,552 B2
Filed 03/08/2010
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Bluesky Medical Group Inc.
|
Dual drug delivery device | ||
Patent #
US 8,323,246 B2
Filed 12/08/2008
|
Current Assignee
University of Michigan
|
Sponsoring Entity
University of Michigan
|
Fluid medication delivery device | ||
Patent #
US 8,323,266 B2
Filed 08/10/2010
|
Current Assignee
Avent Incorporated
|
Sponsoring Entity
Kimberly-Clark Worldwide Incorporated
|
Bladder arrangement for microneedle-based drug delivery device | ||
Patent #
US 8,328,757 B2
Filed 01/08/2010
|
Current Assignee
Wisconsin Alumni Research Foundation
|
Sponsoring Entity
Wisconsin Alumni Research Foundation
|
Fluid delivery device with a diffusion membrane and electrochemical pump | ||
Patent #
US 8,348,930 B2
Filed 03/11/2010
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Gas generation dispenser method for on-demand fluid delivery | ||
Patent #
US 8,353,426 B2
Filed 12/12/2011
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Electrochemical wound therapy | ||
Patent #
US 8,353,928 B2
Filed 07/22/2011
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Drug delivery device | ||
Patent #
US 8,361,027 B2
Filed 07/15/2011
|
Current Assignee
Alkermes Pharma Ireland Limited
|
Sponsoring Entity
Alkermes Pharma Ireland Limited
|
Drug delivery device | ||
Patent #
US 8,361,028 B2
Filed 07/15/2011
|
Current Assignee
Alkermes Pharma Ireland Limited
|
Sponsoring Entity
Alkermes Pharma Ireland Limited
|
Multi-cartridge fluid delivery device | ||
Patent #
US 8,361,053 B2
Filed 01/25/2011
|
Current Assignee
Valeritas LLC
|
Sponsoring Entity
Valeritas LLC
|
Flow regulating stopcocks and related methods | ||
Patent #
US 8,408,421 B2
Filed 10/29/2008
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Transdermal drug delivery method and system | ||
Patent #
US 8,440,221 B2
Filed 09/15/2004
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Slideable flow metering devices and related methods | ||
Patent #
US 8,448,824 B2
Filed 02/26/2009
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Flexible reduced pressure treatment appliance | ||
Patent #
US 8,449,509 B2
Filed 07/07/2010
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Bluesky Medical Group Inc.
|
Device and method for wound therapy | ||
Patent #
US 8,460,255 B2
Filed 11/18/2009
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Kalypto Medical Inc.
|
Reduced pressure treatment system | ||
Patent #
US 8,545,464 B2
Filed 04/23/2012
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Bluesky Medical Group Inc.
|
Gas-pressured medication delivery device | ||
Patent #
US 8,551,071 B2
Filed 03/18/2011
|
Current Assignee
Halozyme Inc.
|
Sponsoring Entity
Halozyme Inc.
|
Programmable implantable pump design | ||
Patent #
US 8,568,360 B2
Filed 12/28/2011
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Wound cleansing apparatus in-situ | ||
Patent #
US 8,569,566 B2
Filed 11/22/2011
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Multiple reservoir programmable pump | ||
Patent #
US 8,591,456 B2
Filed 12/28/2011
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Reduced size implantable pump | ||
Patent #
US 8,591,478 B2
Filed 06/07/2012
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Reduced pressure treatment system | ||
Patent #
US 8,628,505 B2
Filed 11/22/2011
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Bluesky Medical Group Inc.
|
Vaginal hygiene system | ||
Patent #
US 8,641,687 B2
Filed 07/06/2012
|
Current Assignee
JICL IP COMPANY LLC
|
Sponsoring Entity
JICL IP COMPANY LLC
|
Solute concentration measurement device and related methods | ||
Patent #
US 8,650,937 B2
Filed 09/18/2009
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
GAS CELL DRIVEN ORIENTATION INDEPENDENT DELIVERY DEVICE | ||
Patent #
US 20140057174A1
Filed 08/26/2013
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Negative pressure wound therapy device | ||
Patent #
US 8,663,198 B2
Filed 04/16/2010
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Kalypto Medical Inc.
|
Transdermal drug delivery method and system | ||
Patent #
US 8,673,346 B2
Filed 05/10/2013
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
GAS-PRESSURED MEDICATION DELIVERY SERVICE | ||
Patent #
US 20140094769A1
Filed 09/23/2013
|
Current Assignee
Halozyme Inc.
|
Sponsoring Entity
Halozyme Inc.
|
Drug delivery system for treating erectile dysfunction | ||
Patent #
US 8,702,685 B2
Filed 11/15/2010
|
Current Assignee
Douglas Robert Matthew, Schwartz Matthew Zane
|
Sponsoring Entity
Douglas Robert Matthew, Schwartz Matthew Zane
|
Pumping device, as for enteral feeding assembly | ||
Patent #
US 8,715,238 B2
Filed 07/22/2011
|
Current Assignee
Medela Holding AG
|
Sponsoring Entity
Medela Holding AG
|
Vacuum assisted wound dressing | ||
Patent #
US 8,715,256 B2
Filed 11/20/2008
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like | ||
Patent #
US 8,741,336 B2
Filed 06/04/2012
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,758,323 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Infusion device pump | ||
Patent #
US 8,758,308 B2
Filed 02/12/2007
|
Current Assignee
Calibra Medical Inc.
|
Sponsoring Entity
Calibra Medical Inc.
|
MEMS device and method for delivery of therapeutic agents | ||
Patent #
US 8,764,708 B2
Filed 06/11/2012
|
Current Assignee
University of Southern California
|
Sponsoring Entity
University of Southern California
|
Wound dressing | ||
Patent #
US 8,764,732 B2
Filed 11/20/2008
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Automatic motor driven in-line piston pump lubricator | ||
Patent #
US 8,783,418 B2
Filed 05/06/2005
|
Current Assignee
STEPHANIA HOLDINGS INC.
|
Sponsoring Entity
STEPHANIA HOLDINGS INC.
|
Flexible reduced pressure treatment appliance | ||
Patent #
US 8,795,243 B2
Filed 03/08/2010
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Bluesky Medical Group Inc.
|
Multiple reservoir programmable pump | ||
Patent #
US 8,808,231 B2
Filed 10/16/2013
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Wound dressing | ||
Patent #
US 8,808,274 B2
Filed 11/20/2008
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Multi-cartridge fluid delivery device | ||
Patent #
US 8,821,443 B2
Filed 12/19/2012
|
Current Assignee
Valeritas LLC
|
Sponsoring Entity
Valeritas LLC
|
Self contained wound dressing with micropump | ||
Patent #
US 8,829,263 B2
Filed 05/30/2012
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Smith Nephew Incorporated
|
In-situ wound cleansing apparatus | ||
Patent #
US 8,834,451 B2
Filed 01/31/2012
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Variable flow infusion pump system | ||
Patent #
US 8,915,893 B2
Filed 12/28/2011
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Fill-status sensors for drug pump devices | ||
Patent #
US 8,920,376 B2
Filed 04/20/2011
|
Current Assignee
MiniPumps LLC
|
Sponsoring Entity
MiniPumps LLC
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 8,926,561 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Device for delivery of volatile liquids to gaseous environment utilizing a gas generating cell | ||
Patent #
US 8,939,435 B2
Filed 06/04/2012
|
Current Assignee
John Howard Gordon, Ashok V. Joshi
|
Sponsoring Entity
John Howard Gordon, Ashok V. Joshi
|
Two-part, wall-mountable electrochemical dispenser | ||
Patent #
US 8,944,342 B2
Filed 11/01/2011
|
Current Assignee
M R CONSULTING SERVICES INC.
|
Sponsoring Entity
M R CONSULTING SERVICES INC.
|
Dual drug delivery device | ||
Patent #
US 8,945,052 B2
Filed 10/31/2012
|
Current Assignee
Board of Regents of the University of Michigan
|
Sponsoring Entity
Board of Regents of the University of Michigan
|
Device with controller and pump modules for providing negative pressure for wound therapy | ||
Patent #
US 8,945,074 B2
Filed 09/28/2011
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Kalypto Medical Inc.
|
Programmable implantable pump design | ||
Patent #
US 8,961,466 B2
Filed 10/16/2013
|
Current Assignee
Aqulinx Medical Inc.
|
Sponsoring Entity
PALYON MEDICAL BVI LIMITED
|
Two chamber pumps and related methods | ||
Patent #
US 8,986,253 B2
Filed 08/07/2009
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Method for providing a negative pressure wound therapy pump device | ||
Patent #
US 9,058,634 B2
Filed 11/18/2011
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Kalypto Medical Inc.
|
Wound dressing and method of use | ||
Patent #
US 9,061,095 B2
Filed 04/21/2011
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Drug delivery device | ||
Patent #
US 9,061,097 B2
Filed 06/07/2011
|
Current Assignee
Amgen Incorporated
|
Sponsoring Entity
Amgen Incorporated
|
Method for providing negative pressure to a negative pressure wound therapy bandage | ||
Patent #
US 9,067,003 B2
Filed 11/18/2011
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Kalypto Medical Inc.
|
Hydraulically actuated pump for long duration medicament administration | ||
Patent #
US 9,072,828 B2
Filed 12/16/2008
|
Current Assignee
Valeritas Inc.
|
Sponsoring Entity
Valeritas Inc.
|
Methods and devices for delivering GLP-1 and uses thereof | ||
Patent #
US 9,089,636 B2
Filed 07/05/2005
|
Current Assignee
Valeritas Inc.
|
Sponsoring Entity
Valeritas Inc.
|
Drug-delivery pumps and methods of manufacture | ||
Patent #
US 9,107,995 B2
Filed 06/07/2013
|
Current Assignee
MiniPumps LLC
|
Sponsoring Entity
MiniPumps LLC
|
Hydraulically actuated pump for fluid administration | ||
Patent #
US 9,125,983 B2
Filed 04/17/2010
|
Current Assignee
Valeritas Inc.
|
Sponsoring Entity
Valeritas Inc.
|
Drug delivery device | ||
Patent #
US 9,132,231 B2
Filed 09/14/2012
|
Current Assignee
Alkermes Pharma Ireland Limited
|
Sponsoring Entity
Alkermes Pharma Ireland Limited
|
Fluid holder and electromechanical lubricator employing same | ||
Patent #
US 9,151,443 B2
Filed 02/10/2013
|
Current Assignee
STEPHANIA HOLDINGS INC.
|
Sponsoring Entity
STEPHANIA HOLDINGS INC.
|
Method for Fluid Delivery | ||
Patent #
US 20150283031A1
Filed 11/10/2014
|
Current Assignee
Deka Products Limited Partnership
|
Sponsoring Entity
Deka Products Limited Partnership
|
Drug-delivery pumps and methods of manufacture | ||
Patent #
US 9,162,024 B2
Filed 05/08/2009
|
Current Assignee
MiniPumps LLC
|
Sponsoring Entity
MiniPumps LLC
|
Methods and devices for multiple fluid transfer | ||
Patent #
US 9,180,242 B2
Filed 05/17/2012
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Drug-delivery pumps with dynamic, adaptive control | ||
Patent #
US 9,199,035 B2
Filed 08/18/2010
|
Current Assignee
MiniPumps LLC
|
Sponsoring Entity
MiniPumps LLC
|
Flexible reduced pressure treatment appliance | ||
Patent #
US 9,198,801 B2
Filed 05/24/2013
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Bluesky Medical Group Inc.
|
Apparatus for aspirating, irrigating and cleansing wounds | ||
Patent #
US 9,205,001 B2
Filed 09/12/2014
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 9,211,377 B2
Filed 07/29/2010
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Reduced pressure treatment system | ||
Patent #
US 9,211,365 B2
Filed 12/27/2013
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Bluesky Medical Group Inc.
|
Wound dressing | ||
Patent #
US 9,220,822 B2
Filed 05/13/2014
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Apparatus and methods for delivering therapeutic agents | ||
Patent #
US 9,271,866 B2
Filed 06/28/2013
|
Current Assignee
University of Southern California
|
Sponsoring Entity
University of Southern California
|
Flexible reduced pressure treatment appliance | ||
Patent #
US 9,272,080 B2
Filed 07/30/2014
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Bluesky Medical Group Inc.
|
Drug-delivery pump with dynamic, adaptive control | ||
Patent #
US 9,283,322 B2
Filed 07/11/2013
|
Current Assignee
MiniPumps LLC
|
Sponsoring Entity
MiniPumps LLC
|
Apparatus and methods for delivering therapeutic agents | ||
Patent #
US 9,308,124 B2
Filed 12/19/2008
|
Current Assignee
University of Southern California
|
Sponsoring Entity
University of Southern California
|
Drug-delivery pump with intelligent control | ||
Patent #
US 9,333,297 B2
Filed 09/24/2013
|
Current Assignee
MiniPumps LLC
|
Sponsoring Entity
MiniPumps LLC
|
Wound cleansing apparatus in-situ | ||
Patent #
US 9,446,178 B2
Filed 08/17/2011
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Wound cleansing apparatus in-situ | ||
Patent #
US 9,452,248 B2
Filed 12/18/2014
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Reduced pressure wound treatment system | ||
Patent #
US 9,492,326 B2
Filed 05/07/2013
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Bluesky Medical Group Inc.
|
Portable drug delivery device including a detachable and replaceable administration or dosing element | ||
Patent #
RE46217E1
Filed 02/05/2015
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Hydraulically actuated pump for fluid administration | ||
Patent #
US 9,511,187 B2
Filed 07/27/2015
|
Current Assignee
Valeritas Inc.
|
Sponsoring Entity
Valeritas Inc.
|
Two-part, syringe-based electrochemical dispenser | ||
Patent #
US 9,550,008 B2
Filed 10/12/2011
|
Current Assignee
M R CONSULTING SERVICES INC.
|
Sponsoring Entity
M R CONSULTING SERVICES INC.
|
Medicament delivery apparatus | ||
Patent #
US 9,550,050 B2
Filed 09/20/2007
|
Current Assignee
Progenity Inc.
|
Sponsoring Entity
Medimetrics Personalized Drug Delivery B.V.
|
Transdermal drug delivery method and system | ||
Patent #
US 9,555,226 B2
Filed 06/22/2015
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Biosynchronous transdermal drug delivery | ||
Patent #
US 9,555,227 B2
Filed 06/22/2015
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Infusion pump system with disposable cartridge having pressure venting and pressure feedback | ||
Patent #
US 9,555,186 B2
Filed 03/15/2013
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Negative pressure wound therapy device | ||
Patent #
US 9,579,431 B2
Filed 02/13/2014
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Kalypto Medical Inc.
|
Implantable pumps and cannulas therefor | ||
Patent #
US 9,623,174 B2
Filed 05/08/2009
|
Current Assignee
MiniPumps LLC
|
Sponsoring Entity
MiniPumps LLC
|
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like | ||
Patent #
US 9,669,199 B2
Filed 05/02/2014
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Multi-cartridge fluid delivery device | ||
Patent #
US 9,687,599 B2
Filed 07/28/2014
|
Current Assignee
Valeritas LLC
|
Sponsoring Entity
Valeritas LLC
|
MEMS device and method for delivery of therapeutic agents | ||
Patent #
US 9,693,894 B2
Filed 06/03/2014
|
Current Assignee
University of Southern California
|
Sponsoring Entity
University of Southern California
|
Two-part, wall-mountable electrochemical dispenser | ||
Patent #
US 9,695,517 B2
Filed 12/29/2014
|
Current Assignee
M R CONSULTING SERVICES INC.
|
Sponsoring Entity
M R CONSULTING SERVICES INC.
|
Pump device with multiple medicament reservoirs | ||
Patent #
US 9,750,871 B2
Filed 11/10/2015
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Wound dressing and method of use | ||
Patent #
US 9,808,561 B2
Filed 05/18/2015
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Gas cell driven orientation independent delivery device | ||
Patent #
US 9,840,361 B2
Filed 08/26/2013
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Microlin LLC
|
Wound dressing | ||
Patent #
US 9,844,475 B2
Filed 05/31/2016
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Apparatus for aspirating, irrigating and cleansing wounds | ||
Patent #
US 9,844,473 B2
Filed 12/29/2014
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Apparatus for aspirating, irrigating and cleansing wounds | ||
Patent #
US 9,844,474 B2
Filed 12/30/2014
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Drug-delivery pump with intelligent control | ||
Patent #
US 9,849,238 B2
Filed 09/24/2013
|
Current Assignee
MiniPumps LLC
|
Sponsoring Entity
MiniPumps LLC
|
Drug-delivery pumps and methods of manufacture | ||
Patent #
US 9,861,525 B2
Filed 07/17/2015
|
Current Assignee
MiniPumps LLC
|
Sponsoring Entity
MiniPumps LLC
|
Flexible reduced pressure treatment appliance | ||
Patent #
US 9,925,313 B2
Filed 01/11/2016
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Smith Nephew Incorporated
|
Wound dressing | ||
Patent #
US 9,956,121 B2
Filed 04/22/2014
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
System and method for detecting occlusions in an infusion pump | ||
Patent #
US 9,962,486 B2
Filed 11/02/2015
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Vacuum assisted wound dressing | ||
Patent #
US 9,962,474 B2
Filed 04/16/2014
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Wound dressing | ||
Patent #
US 10,016,309 B2
Filed 09/29/2015
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Reduced pressure treatment system | ||
Patent #
US 10,058,642 B2
Filed 11/08/2010
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Smith Nephew Incorporated
|
Optimized bio-synchronous bioactive agent delivery system | ||
Patent #
US 10,105,487 B2
Filed 01/16/2014
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Method for fluid delivery | ||
Patent #
US 10,105,286 B2
Filed 11/10/2014
|
Current Assignee
Deka Products Limited Partnership
|
Sponsoring Entity
Deka Products Limited Partnership
|
Reduced pressure treatment system | ||
Patent #
US 10,105,471 B2
Filed 04/09/2013
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Smith Nephew Incorporated
|
Negative pressure wound therapy device | ||
Patent #
US 10,111,991 B2
Filed 09/28/2016
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Smith Nephew Inc.
|
Apparatus and methods for delivering therapeutic agents | ||
Patent #
US 10,117,774 B2
Filed 06/28/2013
|
Current Assignee
University of Southern California
|
Sponsoring Entity
University of Southern California
|
Wound dressing | ||
Patent #
US 10,123,909 B2
Filed 04/21/2015
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Wound dressing and method of use | ||
Patent #
US 10,159,604 B2
Filed 06/26/2017
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Self contained wound dressing with micropump | ||
Patent #
US 10,201,644 B2
Filed 09/08/2014
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Smith Nephew Incorporated
|
Flexible reduced pressure treatment appliance | ||
Patent #
US 10,207,035 B2
Filed 05/26/2017
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Smith Nephew Incorporated
|
Drug delivery methods and systems | ||
Patent #
US 10,213,586 B2
Filed 01/28/2016
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Wound dressing | ||
Patent #
US 10,231,875 B2
Filed 05/31/2017
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Drug delivery methods and systems | ||
Patent #
US 10,232,156 B2
Filed 09/08/2017
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like | ||
Patent #
US 10,258,738 B2
Filed 04/21/2017
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like | ||
Patent #
US 10,258,778 B2
Filed 03/14/2017
|
Current Assignee
Chrono Therapeutics Inc.
|
Sponsoring Entity
Chrono Therapeutics Inc.
|
Systems including vial adapter for fluid transfer | ||
Patent #
US 10,258,736 B2
Filed 01/04/2017
|
Current Assignee
Tandem Diabetes Care Incorporated
|
Sponsoring Entity
Tandem Diabetes Care Incorporated
|
Reduced pressure treatment system | ||
Patent #
US 10,265,445 B2
Filed 09/15/2015
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Smith Nephew Incorporated
|
Apparatus for aspirating, irrigating and cleansing wounds | ||
Patent #
US 10,278,869 B2
Filed 07/11/2017
|
Current Assignee
Smith Nephew PLC
|
Sponsoring Entity
Smith Nephew PLC
|
Auto-replenishing, wound-dressing apparatus and method | ||
Patent #
US 10,279,156 B2
Filed 06/16/2014
|
Current Assignee
Aplion Medical LLC
|
Sponsoring Entity
Aplion Medical LLC
|
Method for providing negative pressure to a negative pressure wound therapy bandage | ||
Patent #
US 10,300,178 B2
Filed 06/11/2015
|
Current Assignee
Smith Nephew Inc.
|
Sponsoring Entity
Smith Nephew Inc.
|
Pneumatically coupled direct drive fluid control system and process | ||
Patent #
US 10,342,920 B2
Filed 04/18/2016
|
Current Assignee
TURNPOINT MEDICAL DEVICES INC.
|
Sponsoring Entity
TURNPOINT MEDICAL DEVICES INC.
|
Single dose drug delivery device | ||
Patent #
US 10,342,926 B2
Filed 05/26/2017
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Flexible reduced pressure treatment appliance | ||
Patent #
US 10,350,339 B2
Filed 05/17/2017
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Smith Nephew Incorporated
|
Pneumatically coupled fluid control system and process with air detection and elimination | ||
Patent #
US 10,350,352 B2
Filed 05/22/2014
|
Current Assignee
TURNPOINT MEDICAL DEVICES INC.
|
Sponsoring Entity
TURNPOINT MEDICAL DEVICES INC.
|
Flexible reduced pressure treatment appliance | ||
Patent #
US 10,363,346 B2
Filed 11/23/2015
|
Current Assignee
Smith Nephew Incorporated
|
Sponsoring Entity
Smith Nephew Incorporated
|
Multi-dose drug delivery device | ||
Patent #
US 10,363,374 B2
Filed 05/26/2017
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Plunger for drug delivery device | ||
Patent #
US 10,363,372 B2
Filed 08/11/2017
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Variable fill drug delivery device | ||
Patent #
US 10,441,723 B2
Filed 08/14/2017
|
Current Assignee
Insulet Corporation
|
Sponsoring Entity
Insulet Corporation
|
Controlled release portable pump | ||
Patent #
US 5,492,534 A
Filed 05/20/1994
|
Current Assignee
Flora Incorporated
|
Sponsoring Entity
Flora Incorporated
|
Apparatus and methods for multiple fluid infusion | ||
Patent #
US 5,578,005 A
Filed 09/16/1994
|
Current Assignee
ALISANAE GROUP LIMITED
|
Sponsoring Entity
RIVER MEDICAL INC.
|
Needleless hypodermic injection device | ||
Patent #
US 5,383,851 A
Filed 07/24/1992
|
Current Assignee
Bioject Incorporated
|
Sponsoring Entity
Bioject Incorporated
|
Electronic transdermal drug delivery system | ||
Patent #
US 5,405,614 A
Filed 01/11/1993
|
Current Assignee
AMERICARE TECHNOLOGIES INC.
|
Sponsoring Entity
INTERNATIONAL MEDICAL ASSOCIATES INC.
|
Programmable apparatus for the transdermal delivery of drugs and method | ||
Patent #
US 5,415,629 A
Filed 09/15/1993
|
Current Assignee
MEDICAL IONOSONIC TECHNOLOGIES LLP
|
Sponsoring Entity
Henley Julian L.
|
Gas releasing electrochemical cell for fluid dispensing applications | ||
Patent #
US 5,427,870 A
Filed 09/06/1994
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Ceramatec Inc.
|
Skin surface peeling process using laser | ||
Patent #
US 5,423,803 A
Filed 06/08/1994
|
Current Assignee
ThermoLase Corp.
|
Sponsoring Entity
THERMOTREX CORPORATION THERMOLASE CORPORATION
|
Transdermal perfusion of fluids | ||
Patent #
US 5,441,490 A
Filed 11/23/1993
|
Current Assignee
Pal Svedman
|
Sponsoring Entity
Pal Svedman
|
Delivery devices with pulsatile effect | ||
Patent #
US 5,456,679 A
Filed 12/07/1994
|
Current Assignee
Alza Corporation
|
Sponsoring Entity
Alza Corporation
|
Fluid dispensing pump | ||
Patent #
US 5,454,922 A
Filed 05/07/1993
|
Current Assignee
Microlin LLC
|
Sponsoring Entity
Ceramatec Inc.
|
Transdermal drug delivery by electroincorporation of vesicles | ||
Patent #
US 5,464,386 A
Filed 09/22/1994
|
Current Assignee
Genetronics Inc.
|
Sponsoring Entity
Genetronics Inc.
|
Electrochemical controlled dispensing assembly and method for selective and controlled delivery of a dispensing fluid | ||
Patent #
US 5,290,240 A
Filed 02/03/1993
|
Current Assignee
PHARMETRIX CORPORATION
|
Sponsoring Entity
PHARMETRIX CORPORATION
|
Controlled release infusion device | ||
Patent #
US 5,318,540 A
Filed 10/06/1992
|
Current Assignee
Pharmetrix Corporation
|
Sponsoring Entity
Pharmetrix Corporation
|
Gas pressure driven infusion system by hydrogel electrolysis | ||
Patent #
US 5,354,264 A
Filed 02/17/1993
|
Current Assignee
Harvey Jacobs
|
Sponsoring Entity
Harvey Jacobs
|
Electrochemical controlled dispensing assembly and method | ||
Patent #
US 5,368,571 A
Filed 02/01/1994
|
Current Assignee
PHARMETRIX CORPORATION
|
Sponsoring Entity
PHARMETRIX CORPORATION
|
Method of eliminating stratum corneum from the skin and an instrument to be used therefor | ||
Patent #
US 5,190,558 A
Filed 11/07/1990
|
Current Assignee
NEC Corporation
|
Sponsoring Entity
NEC Corporation
|
Device for electrochemical generation of gases for the transportation of fluids and similar mediums | ||
Patent #
US 5,242,565 A
Filed 07/10/1991
|
Current Assignee
August Winsel
|
Sponsoring Entity
August Winsel
|
Electrochemically driven metering medicament dispenser | ||
Patent #
US 5,090,963 A
Filed 10/19/1990
|
Current Assignee
Elan Corporation PLC
|
Sponsoring Entity
S.I. SCIENTIFIC INNOVATIONS LTD.
|
Device for delivering a pharmacologically active principle by electrolytic pumping | ||
Patent #
US 5,135,499 A
Filed 03/11/1991
|
Current Assignee
APCIS
|
Sponsoring Entity
APCIS
|
Controlled release infusion device | ||
Patent #
US 5,135,498 A
Filed 04/02/1990
|
Current Assignee
PHARMETRIX CORPORATION A CORP. OF DE.
|
Sponsoring Entity
PHARMETRIX CORPORATION A CORP. OF DE.
|
Multiple vesicle implantable drug delivery system | ||
Patent #
US 5,167,625 A
Filed 10/09/1990
|
Current Assignee
University of Utah Research Foundation
|
Sponsoring Entity
University of Utah Research Foundation
|
Device for administering fluid drugs, in particular for infusion | ||
Patent #
US 5,041,094 A
Filed 05/22/1989
|
Current Assignee
SOCIETE A RESPONSABILITE LIMITEE DITE SOCIETE DE PRODUITS POUR LINDUSTRIE LA RECHERCHE ET LES ANALYSES DE LABORATOIRES S.P.I.R.A.L.
|
Sponsoring Entity
SOCIETE A RESPONSABILITE LIMITEE DITE SOCIETE DE PRODUITS POUR LINDUSTRIE LA RECHERCHE ET LES ANALYSES DE LABORATOIRES S.P.I.R.A.L.
|
Pressure-sensitive adhesive compositions suitable for medical uses | ||
Patent #
US 5,045,601 A
Filed 06/13/1989
|
Current Assignee
BIOINTERFACE TECHNOLOGIES INC.
|
Sponsoring Entity
BIOINTERFACE TECHNOLOGIES INC.
|
Device for dispensing a liquid particularly useful for delivering medicaments at a predetermined rate | ||
Patent #
US 5,062,834 A
Filed 08/15/1989
|
Current Assignee
Elan Corporation PLC
|
Sponsoring Entity
S.I. SCIENTIFIC INNOVATIONS LTD.
|
Portable infusion device assembly | ||
Patent #
US 4,898,582 A
Filed 08/09/1988
|
Current Assignee
Pharmetrix Corporation
|
Sponsoring Entity
Pharmetrix Corporation
|
Infusion apparatus | ||
Patent #
US 4,966,585 A
Filed 05/31/1988
|
Current Assignee
Gangemi Ronald J.
|
Sponsoring Entity
Gangemi Ronald J.
|
Infusion device | ||
Patent #
US 4,969,874 A
Filed 11/25/1988
|
Current Assignee
Disetronic Licensing Ag
|
Sponsoring Entity
DISETRONIC AG. A SWISS CORP.
|
Device for dispensing active substances to a patient | ||
Patent #
US 4,969,873 A
Filed 06/22/1989
|
Current Assignee
PALYON MEDICAL BVI LIMITED
|
Sponsoring Entity
ANNEMARIE SCHLOGL GESELLSCHAFT M.B.H. CO. KG
|
Infusion method and means | ||
Patent #
US 4,850,971 A
Filed 02/23/1988
|
Current Assignee
PYRAMID TECHNOLOGIES INTERNATIONAL INC.
|
Sponsoring Entity
TRIANGLE RESEARCH AND DEVELOPMENT CORPORATION
|
Portable injection appliance | ||
Patent #
US 4,886,499 A
Filed 12/04/1987
|
Current Assignee
Hoffmann-La Roche Incorporated
|
Sponsoring Entity
Hoffmann-La Roche Incorporated
|
Ambulatory drug delivery device | ||
Patent #
US 4,734,092 A
Filed 02/18/1987
|
Current Assignee
Alaris Medical Systems Incorporated
|
Sponsoring Entity
Ivax Corporation
|
Infusion pump | ||
Patent #
US 4,744,786 A
Filed 06/17/1986
|
Current Assignee
NMT NEUROSCIENCES IP INC.
|
Sponsoring Entity
Cordis Corporation
|
Ultrasound enhancement of transdermal drug delivery | ||
Patent #
US 4,767,402 A
Filed 07/08/1986
|
Current Assignee
Massachusetts Institute of Technology
|
Sponsoring Entity
Massachusetts Institute of Technology
|
Controlled removal of human stratum corneum by pulsed laser to enhance percutaneous transport | ||
Patent #
US 4,775,361 A
Filed 04/10/1986
|
Current Assignee
General Hospital Corporation
|
Sponsoring Entity
General Hospital Corporation
|
Spring-operated liquid-dispensing device | ||
Patent #
US 4,781,689 A
Filed 11/13/1986
|
Current Assignee
Andrew Sealfon, Carl Yurdin
|
Sponsoring Entity
Andrew Sealfon, Carl Yurdin
|
Syringe injector | ||
Patent #
US 4,634,431 A
Filed 05/16/1983
|
Current Assignee
Martin J. Kell III, Douglass G. Whitney
|
Sponsoring Entity
Martin J. Kell III, Douglass G. Whitney
|
Intravenous fluid infusion device | ||
Patent #
US 4,636,197 A
Filed 02/15/1985
|
Current Assignee
Ping Chu
|
Sponsoring Entity
Ping Chu
|
Portable and wearable injector of mini size | ||
Patent #
US 4,640,445 A
Filed 12/20/1984
|
Current Assignee
Nikkiso Company Limited
|
Sponsoring Entity
Nikkiso Company Limited
|
Drug-injection animal capture collar | ||
Patent #
US 4,652,261 A
Filed 06/22/1984
|
Current Assignee
Board of Trustees of The University of Illinois
|
Sponsoring Entity
Board of Trustees of The University of Illinois
|
Portable self-contained injector for perfusions, particularly in the case of road accident victims | ||
Patent #
US 4,673,392 A
Filed 10/02/1985
|
Current Assignee
Bernard M. Keime
|
Sponsoring Entity
Bernard M. Keime
|
Electrochemically-driven pulsatile drug dispenser | ||
Patent #
US 4,687,423 A
Filed 06/07/1985
|
Current Assignee
Alaris Medical Systems Incorporated
|
Sponsoring Entity
Ivax Corporation
|
Therapeutic agent delivery system and method | ||
Patent #
US 4,715,850 A
Filed 12/06/1984
|
Current Assignee
TRAN LOI
|
Sponsoring Entity
CONTROLLED RELEASE TECHNOLOGIES INC.
|
Liquid delivery system particularly useful as an implantable micropump for delivering insulin or other drugs | ||
Patent #
US 4,596,575 A
Filed 05/23/1984
|
Current Assignee
BESPAK PLC
|
Sponsoring Entity
OMIKRON SCIENTIFIC LTD. AN ISRAELI COMPANY
|
Implantable medication infusion device | ||
Patent #
US 4,626,244 A
Filed 02/01/1985
|
Current Assignee
Eaton Corporation
|
Sponsoring Entity
CONSOLIDATED CONTROLS CORPORATION
|
Wearable medication infusion system with arcuated reservoir | ||
Patent #
US 4,525,164 A
Filed 04/24/1981
|
Current Assignee
BioTex Incorporated
|
Sponsoring Entity
BioTex Incorporated
|
Body mounted pump housing and pump assembly employing the same | ||
Patent #
US 4,552,561 A
Filed 12/23/1982
|
Current Assignee
Alza Corporation
|
Sponsoring Entity
Alza Corporation
|
Infusion pump | ||
Patent #
US 4,561,856 A
Filed 08/18/1983
|
Current Assignee
Ulrich D. Cochran
|
Sponsoring Entity
Ulrich D. Cochran
|
Spring-operated liquid-dispensing device | ||
Patent #
US 4,447,232 A
Filed 05/21/1982
|
Current Assignee
Repro-Med Systems Incorporated
|
Sponsoring Entity
Repro-Med Systems Incorporated
|
Surgically implantable pump | ||
Patent #
US 4,457,752 A
Filed 09/13/1982
|
Current Assignee
Vadasz Csaba
|
Sponsoring Entity
-
|
Self-driven pump assembly and method of operation | ||
Patent #
US 4,474,575 A
Filed 09/22/1982
|
Current Assignee
Alza Corporation
|
Sponsoring Entity
Alza Corporation
|
Device for the infusion of fluids into the human or animal body | ||
Patent #
US 4,395,259 A
Filed 09/14/1981
|
Current Assignee
Siemens AG
|
Sponsoring Entity
Siemens AG
|
Injection device and method | ||
Patent #
US 4,351,335 A
Filed 03/23/1981
|
Current Assignee
Douglass G. Whitney, Martin John K. III
|
Sponsoring Entity
Douglass G. Whitney, Martin John K. III
|
Implantable infusion device | ||
Patent #
US 4,360,019 A
Filed 03/31/1980
|
Current Assignee
Baxter International Inc.
|
Sponsoring Entity
Andros Incorporated
|
Implantable infusion device | ||
Patent #
US 4,265,241 A
Filed 02/28/1979
|
Current Assignee
Baxter International Inc.
|
Sponsoring Entity
Andros Incorporated
|
Method of delivering drug with aid of effervescent activity generated in environment of use | ||
Patent #
US 4,265,874 A
Filed 04/25/1980
|
Current Assignee
Alza Corporation
|
Sponsoring Entity
Alza Corporation
|
Bladder for liquid dispenser | ||
Patent #
US 4,201,207 A
Filed 11/26/1976
|
Current Assignee
Alza Corporation
|
Sponsoring Entity
Alza Corporation
|
Osmotically triggered device with gas generating means | ||
Patent #
US 4,203,441 A
Filed 12/18/1978
|
Current Assignee
Alza Corporation
|
Sponsoring Entity
Alza Corporation
|
Implantable dosing device | ||
Patent #
US 4,140,122 A
Filed 06/02/1977
|
Current Assignee
Siemens AG
|
Sponsoring Entity
-
|
Clockwork driven hypodermic syringe | ||
Patent #
US 4,059,110 A
Filed 10/07/1976
|
Current Assignee
Timex Corporation
|
Sponsoring Entity
Timex Corporation
|
Implantable infusate pump | ||
Patent #
US 3,951,147 A
Filed 04/07/1975
|
Current Assignee
SHILEY INFUSAID INC.
|
Sponsoring Entity
Metal Bellows Company
|
PRESSURE INFUSION DEVICE FOR MEDICAL USE | ||
Patent #
US 3,506,005 A
Filed 02/23/1967
|
Current Assignee
BAXTER INTERNATIONAL INC. ONE BAXTER PARKWAY DEERFIELD ILLINOIS 60015 A DE. CORP.
|
Sponsoring Entity
GORTZ NORMAN, Maccarone Michael B., Gilio Arthur S.
|
MEDICAL LIQUID ADMINISTRATION DEVICE | ||
Patent #
US 3,640,277 A
Filed 12/09/1968
|
Current Assignee
Marvin Adelberg
|
Sponsoring Entity
Marvin Adelberg
|
Device for supplying medicines | ||
Patent #
US 3,894,538 A
Filed 08/06/1973
|
Current Assignee
Siemens AG
|
Sponsoring Entity
Siemens AG
|
Hypodermic injector | ||
Patent #
US 2,832,339 A
Filed 09/02/1953
|
Current Assignee
Potter David M., Stanley J. Sarnoff
|
Sponsoring Entity
Potter David M., Stanley J. Sarnoff
|
Device for continuous delivery of metered amounts of liquid | ||
Patent #
US 3,115,280 A
Filed 06/07/1961
|
Current Assignee
Samuel P. Battista
|
Sponsoring Entity
Samuel P. Battista
|
PRESSURE INFUSION DEVICE FOR AMBULATORY PATIENTS WITH PRESSURE CONTROL MEANS | ||
Patent #
US 3,468,308 A
Filed 01/17/1966
|
Current Assignee
Howard R. Bierman
|
Sponsoring Entity
Howard R. Bierman
|
GAS ACTUATED HYPODERMIC SYRINGE | ||
Patent #
US 3,433,224 A
Filed 03/05/1968
|
Current Assignee
Black Robert B.
|
Sponsoring Entity
Black Robert B.
|
Disposable hypodermic syringe | ||
Patent #
US 2,971,509 A
Filed 09/26/1958
|
Current Assignee
Joseph Cohen Milton
|
Sponsoring Entity
Joseph Cohen Milton
|
Hypodermic syringe | ||
Patent #
US 2,545,017 A
Filed 06/02/1947
|
Current Assignee
Gordon D. Billingsley
|
Sponsoring Entity
Gordon D. Billingsley
|
21 Claims
- 1. An apparatus for delivering a fluid, said apparatus comprising:
a housing; a displaceable membrane disposed within said housing, dividing a portion of said housing into a first chamber and a second chamber, said first chamber formed in part, of said housing, said first chamber for containing fluid for delivery and having a port in fluid communication with said first chamber, and said second chamber for containing a driving gas, said displaceable membrane being impermeable to the driving gas; a pump for pressurizing driving gas in said second chamber, thereby exerting a force on said displaceable membrane, thus expelling fluid contained within said first member from said port, said pump comprising an electrochemical gas generation cell; and means for delivering fluid from said port to a desired location. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
1 Specification
The invention relates generally to methods and associated apparatus for controllably delivering fluids, and specifically to methods and associated apparatus for the slow infusion of a fluid, such as a liquid containing a biologically active substance.
In many medical situations it is necessary or desirable to administer small amounts of medicines and other pharmaceutical fluids to a patient'"'"'s body over a relatively long period of time. For example, heparin is administered to a patient in need thereof by an intravenous "drip" procedure. Other medicines which may be administered over long periods of time include antiarrhythmics, streptokinase, "TPA", vitamins, hormones, and corticosteriods. Other medicines that can benefit from prolonged delivery periods include analgesics, anesthetics, antibiotics, cytostatics, and cytotoxics.
These medicines may be administered intermittently by bolus injection or continuously by gravity dispensers. Bolus injections may, however, imperfectly match the patient'"'"'s actual requirements and subject the patient to larger dosages of drugs than required as well as frequent needle insertion. Continuous drug delivery through gravity dispensers may limit the patient'"'"'s lifestyle by tethering him or her to the familiar intravenous drip apparatus. Furthermore, the dispensing rate is not always constant.
Portable units to deliver medicines have been developed that employ mechanical pumps, pressurized gas or the property of an elastic material to return to its original shape. The mechanical pumps use electrical or clockwork motors. The pressurized devices use elastic, inflated balloons or the vapor pressure of a volatile propellant. These devices suffer from many of the drawbacks of the gravity dispensers. Although portable, they generally remain bulky. The mechanical units have moving parts subject to wear and are relatively expensive. They also may have difficulty dispensing small volumes of liquid accurately.
Gas generating devices have been developed that are both portable and accurate for dispensing small volumes. These gas generating methods include osmotic pumps, electrolytic cells, Galvanic cells, and oxygen pumps.
An osmotic pump involves imbibing water or another driving fluid. The ump consists of three chambers: a salt chamber, a water chamber, and a drug chamber. The salt and water chambers are separated by a semipermeable membrane. This membrane is permeable to water but impermeable to salt. The drug chamber is separated from the other two by a flexible diaphragm. Water imbibes osmotically into the salt chamber creating an osmotic pressure which, in turn, exerts a force on the diaphragm thus expelling the drug.
An electrolytic cell comprises a pair of electrodes suspended in an electrolyte. When voltage is applied to the electrodes, the electrolyte gives off a gas which exerts a force on a diaphragm or piston thus expelling the drug.
A Galvanic cell is essentially a metal/electrolyte cell where hydrogen gas is created by reaction of metal with electrolyte thus completing the contact between metal and cathode. The anode and cathode are connected through a resistor. The resistor regulates the current passed through the cell which directly regulates the production of gas.
An oxygen pump transports oxygen from one side of a membrane to the other. Electrodes are placed on opposite surfaces of an electrolytic membrane. Then a voltage gradient is established across the electrolytic membrane. Oxygen is ionized at the first electrode and passes through the membrane where it is reconverted into oxygen at the second electrode. This oxygen can be captured to provide pumping action through the inflation of a bag.
Portable drug delivery systems have been described. For example, U.S. Pat. No. 4,552,561 to Eckenhoff et al. (Nov. 12, 1985) discloses a rigid, tapered housing that is affixed to the wearer by an annular adhesive overlay. Enclosed within the housing is a chamber for the medicament, an imbibing pump, and a traditional needle. One drawback of such a system is that a rigid housing may not easily conform to the contours of the user'"'"'s body. Another problem is that the flow rate of an osmotic pump varies with temperature. A change in body or external temperature could have the undesirable effect of changing the medicament flow. In addition, in order to vary the medicament flow, it may be necessary to provide numerous osmotic pumps with differing outputs, or hydrogels with different osmotic properties, or various impermeable membranes to partially preclude the osmotic pump. These limitations make it difficult for the patient to use and control such devices. Osmotic pumps also require charging (the time required for liquid to diffuse through the semi-permeable membrane and begin dissolving the osmagent at steady state) which delays the delivery of the medicament and which limits their suitability for instantaneous or emergency use.
U.S. Pat. No. 4,734,092 to Millerd (Mar. 29, 1988) discloses a flexible housing that is attached to the subject by an adhesive surface incorporated on the housing. Enclosed in the housing is a pump module, a cannula, and a fluid conduit passageway in the form of a spirally wrapped tube. The pump transports atmospheric oxygen into the tube. Such pumping creates a pressure which drives the medicament through the cannula. An oil slug separates the medicament and oxygen. The device is actuated by removing a peel tab and rotating the pump so that the output of the pump aligns with the input of the spiraled tube. The flow can be controlled by varying the current to the pump with a potentiometer. One drawback of such a device is the use of added components for a filtering system of hydrophobic and hydrophilic membranes to keep oil and oxygen from being administered to the patient. Thus, the hydrophobic membrane keeps the medicament in the device while allowing the oxygen to escape. The hydrophilic membrane allows medicament to pass into the body while obstructing oxygen. The hydrophilic membrane is of limited porosity so that it also impedes oil. Another disadvantage of this device is the protrusion of the cannula while in the storage or non-use stage. This exposes the device to possible damage and contamination. Also, a protruding needle does little to re-assure a traumatized or needle-phobic patient. An additional drawback is the difficulty in manufacturing a device with a spiral wrapped tube.
Another development in drug delivery systems is the transdermal patch. The patch is attached to the skin by an adhesive surface. Medicine then passes through the patch and the skin. A drawback of transdermal drug delivery technology is that certain molecules are very difficult to administer in effective doses. In addition, control of the drug administration may be limited.
The invention relates to an apparatus ideally suited for the slow infusion of a fluid, such as a biologically active material, into a subject'"'"'s (e.g. a mammal'"'"'s) body. The apparatus is inexpensive to manufacture, easy to use, and reliable. In one embodiment, the apparatus is self-contained, inconspicuous and concealable, innocuous in appearance, and capable of being rapidly implemented.
In general, the apparatus includes a housing, a fluid reservoir (or multiple reservoirs) disposed within the housing for storing the fluid to be delivered, a pump to create a driving gas which exerts a force on the fluid reservoir to expel the fluid reservoir'"'"'s contents, and means for fluid delivery (e.g. a cannula, needle or pad),for example, cannula being in fluid communication with the fluid reservoir. The apparatus may further include a pump activation mechanism such as a button and electrical circuit wherein, by pushing the button, one activates the circuit, electrically connecting a power source (e.g. a battery) to the pump. The apparatus may still further include a pump control mechanism (e.g. an electrical circuit that controls the voltage gradient to the pump) so that delivery of the fluid is controlled.
A different housing for use with an apparatus according to the invention includes a displaceable diaphragm dividing the housing into two chambers wherein the first chamber contains the fluid to be delivered, and the second chamber contains a driving gas. The driving gas chamber may include a pressure relief valve or burst (or rupture) disc. A pump may be included to pressurize the driving gas, thus exerting a force on the first chamber to expel the fluid to be delivered, and a cannula or needle in fluid communication with the fluid to be delivered from the first chamber.
Alternatively, the apparatus may include a generally inexpandable housing, a deformable fluid reservoir disposed within the housing, a pressurized driving gas source to exert a force on the fluid reservoir to expel the fluid thus contained, and an associated cannula for controllably and constantly delivering the fluid.
The apparatus may include adhesive or an adhesive layer positioned on the housing'"'"'s surface for adhering the apparatus to the subject'"'"'s body. In such an embodiment, a protective backing can be removed and the apparatus then applied to the subject'"'"'s body. Thus, the apparatus is readily adapted to emergency situations. The apparatus can further utilize either a separate layer of anesthetic and/or antiseptic generally disposed on the surface of the housing in the vicinity of the cannula such that the subject'"'"'s body is desensitized where the cannula will be inserted, or may include such medicaments with the adhesive layer.
In the drawings, which depict preferred embodiments of the invention and in which like reference numerals refer to like parts in different views:
FIG. 1 is a top plan view of a slow infusion subcutaneous fluid delivery apparatus embodying features of the present invention.
FIG. 2 is a side view of the device of FIG. 1.
FIG. 3 is an enlarged cross-sectional view of the apparatus of FIG. 1 with the apparatus being shown in section taken substantially along line 3--3 of FIG. 1 before actuation of the device.
FIG. 4 is another enlarged cross-sectional view of the apparatus of FIG. 1 after actuation.
FIG. 5 schematically depicts circuitry useful in the practice of the invention.
FIG. 6 is an enlarged cross-sectional view of another embodiment of the invention, wherein the apparatus has two reservoirs, and is designed for transdermal drug delivery.
FIG. 7 is a bottom view of the device of FIG. 6.
FIG. 8 is an enlarged view of a lancet for use with the invention of FIGS. 6 and 7.
FIG. 9 is an enlarged cross-sectional view of valving useful in delivering two different fluids from an apparatus according to the invention.
FIG. 10 is an enlarged cross-sectional view of an embodiment of the invention having a needle protrusion and retraction mechanism.
FIG. 11 is an enlarged section view of an embodiment of the invention.
FIG. 12 is an'"'"'enlarged bottom view of the embodiment of the preceding figure.
FIG. 13 is an enlarged section view of an embodiment of the invention.
FIG. 14 is an enlarged bottom view of the embodiment of the preceding figure.
As depicted in FIGS. 1-4, in a preferred embodiment, an apparatus according to the invention, generally 120, includes a bladder or compressible reservoir 154,156 containing a fluid (e.g. a liquid) containing a biologically active substance, such as a medication. This reservoir 154,156 in turn, is associated with (e.g. contained in) a generally inexpandable housing 124.
The apparatus 120 includes a displaceable membrane 158 disposed within the housing such that the reservoir 154,156 is divided into two chambers; the first chamber 154 containing the fluid to be delivered and the second chamber 156 containing the driving gas. Pressure accumulated in the second chamber 156 exerts a force on the first chamber 154 so that the fluid to be delivered is expelled from the first chamber 154 and the flexible membrane 158 (being impermeable to the driving gas) prevents contamination of one fluid with another.
A needle, cannula 150 or other delivery means (e.g. a sponge-like pad) is in fluid communication with the reservoir so that when the reservoir'"'"'s contents are expelled, they will flow through the delivery means. The length of a needle will typically be chosen to be slightly longer than the thickness of the tissue (e.g. skin) to be pierced.
The device has a pump 126 (e.g. a Galvanic cell or metal electrolyte cell), which is preferably, a hydrogen or oxygen pump. The pump may be a gas releasing electrochemical cell such as those disclosed in U.S. Pat. Nos. 5,427,870 (Jun. 27, 1995) and 5,454,922 (Oct. 3, 1995) to Joshi et al., the contents of the entirety of both of which are incorporated by this reference. As shown in FIG. 5, a battery 138 or other energy source may be used to establish a voltage gradient across the permeable membrane 40. Between the battery 138 and the pump 126 is a resistor holder 139. One pole of the battery is connected to an electrode 42. The other pole of the battery is connected to another electrode 44 on the other surface of the membrane. Atmospheric oxygen is ionized at electrode 42. The ions then pass through membrane 40 and are reconverted into oxygen at electrode 44.
The pump may be controlled by an electrical circuit 46 (within dashed lines of FIG. 5). The electrical circuit 46 can be connected between one of the connections between the battery and the cell. The circuit may contain a variable resistor 48 to vary the voltage gradient across the membrane. In addition, a timer 50 and/or alarm 52 could be incorporated into the circuitry to control the delivery of the fluid. In one embodiment, the electronic circuit is controlled by means of a microprocessor, controlling delivery of the fluid for, for example, diurnal or metabolic (e.g. mealtime) variations.
The pump may include its own housing (which may be part of the apparatus housing), an electrolytic membrane disposed in this housing having first and second surfaces, an opening for exposing the first surface to atmospheric oxygen or other source of driving gas (e.g. oxygen or hydrogen), a first material-pervious electrode disposed on the first membrane surface and a second material-pervious electrode disposed on the second membrane surface, and an electrical power source disposed within or on the housing for establishing a voltage gradient across the electrolytic membrane such that the oxygen is ionized at the first electrode, transporting the ions through the electrolytic membrane, wherein the ions evolve into oxygen molecules at the second electrode to become the driving gas. The pump may be an oxygen pump for transferring atmospheric oxygen into the housing and the driving gas comprises oxygen. The pump may alternatively be an electrolytic cell comprising a pair of electrodes suspended in an electrolyte and a voltage source such that when voltage is applied to the electrodes a gas is formed in the electrolyte which exerts a force that expels the liquid, or the pump may be a Galvanic cell.
A separate, replaceable pump module which contains a supply of fluid to be delivered may be used. In such a device, the activation mechanism may be a) temporary (e.g. active only when the module is pressed down, b) semi-permanent (e.g. similar to a retractable ball point pen mechanism), or c) permanent (e.g. once engaged, the device can only be stopped by removing the entire device or the module).
The pump control mechanism may further include a timer 50 such that the flow of the delivery fluid and the flow of the fluid reservoir contents can be timed, or an alarm so that an alarm is sounded on the occurrence of an event such as the passage of time, excessive pressure, excessive volume, etc.
In an alternative embodiment, the pump is replaced by a pressurized housing. This housing is also divided into a first chamber and a second chamber by a displaceable membrane (e.g. a flexible plastic piece). The first chamber contains the fluid to be delivered (e.g. insulin) and the second chamber contains the driving gas (e.g. oxygen or FREON™). The driving gas is pressurized at body temperatures so that it exerts a force on the membrane and expels the fluid to be delivered through the delivery means (e.g. an injection needle).
The fluid flow may be controlled. For example, a rotatable restrictor may be incorporated into the housing. A conduit is contained within the rotatable member. When rotated, one end of the conduit becomes aligned with an output from the fluid reservoir or first chamber while the other end of the conduit becomes aligned with an input of the cannula. When thus aligned, the fluid to be delivered flows through the cannula and is thus delivered. Continued rotation of the rotational member causes the conduit to become misaligned thus slowing or stopping the flow. Such a mechanism may be used to regulate the fluid flow subcutaneously as well as to control the flow of driving gas from the pump into the housing.
In one embodiment, the association between the housing and the reservoir is such that if a pressurized gas were introduced into the housing, the pressure thus created would exert a force on the exterior surface of the compressible reservoir. Also contained in such an apparatus is a pump or cell. The pump transfers a driving gas into the inexpandable housing. This driving gas pressurizes the interior of the housing, thus exerting a force on the exterior of the reservoir. The interior of the reservoir is in fluid communication with a tube or conduit extending away from the reservoir, preferably to the place where the contents of the reservoir are to be delivered. When pressure is exerted on the exterior of the reservoir, the contents of the reservoir are driven into one end of the tube and out the other end for delivery.
The tube or conduit may be comprised of various (e.g. two) distinct sections, and may be used to control the flow of material from the reservoir for delivery. The second section of conduit is contained in a solid rotatable member housed by the housing. By rotating the rotatable member, one end of the first section of the conduit may be brought in partial or complete alignment with a corresponding end of the second section of the conduit. By so doing, the contents of the fluid reservoir may be driven to a needle, cannula or absorbent pad for delivery of the fluid reservoir'"'"'s contents. By controlling the amount of alignment between the two sections of the conduit, the amount of fluid delivered to the cannula can be controlled.
When used for the parenteral administration of a biologically active substance, the second section of the conduit and the lumen of the cannula may be filled with a biologically compatible fluid (e.g. water or normal saline). As used herein, the term "biologically active substance" means all types of medical and biological fluid used in the treatment of humans and animals including but not limited to peptides (such as insulin), analgesics, antiarrhythmics, steroids, hormones, nicotine, vitamins, anti-migraine medicine, anti-coagulants, local anesthetics, vaccines, allergens, muscle relaxants, etc. It should also be recognized that the apparatus is suited for the delivery of fluid into mammals, plants, fish, reptiles, and birds.
The needle or cannula is preferably contained within the housing during storage or when otherwise not in use, and, as described herein in more detail, extends or protrudes through the housing when actuated for use. When activated, the mechanism extends the cannula through the housing for insertion into the subject'"'"'s body upon activation. When finished, the mechanism may then retract the cannula into the housing. This helps to keep the cannula sterilized and also protects against accidental damage. It also has the added benefit of concealing the cannula from people who are traumatized or needle-phobic. In one embodiment (not shown) the cannula activation mechanism is like a retractable pen mechanism; the cannula is extended and retracted by pushing a button associated with the device.
The surface of the housing that abuts or is in contact with the skin may be coated with an adhesive layer for attaching the apparatus to the skin. A protective backing (not shown) may be used to cover the adhesive layer during non-use. The adhesive layer preferably contains anesthetic, antiseptic, or a mixture thereof. When attached to the skin, the anesthetic desensitizes it, while the antiseptic disinfects it.
Alternatively, a chamber of anesthetic or antiseptic (generally disposed between the housing and the skin of the user) may be used to anesthetize or disinfect the local area (not shown).
In the event a transdermal route of administration is selected, transdermal permeation enhancers may be utilized to improve the transport of physiologically active agents through the skin or other membranes of an animal (e.g. a mammal). Transdermal permeation enhancers are disclosed in U.S. Pat. Nos. 3,989,816, 4,316,893, and others to Rajadhyaksha (e.g. lactams such as AZON™), U.S. Pat. No. 4,755,535 to Minaskanian, U.S. Pat. No. 4,699,777 to Zupon et al., U.S. Pat. No. 4,820,711 to Pearlman, U.S. Pat. No. 4,557,934 to Cooper, and U.S. Pat. No. 5,296,222 to Peterson et al., the contents of all of which are hereby incorporated by this reference.
When a device according to the invention uses a transdermal pad to deliver the liquid for administration to a patient, the skin may be pre-treated. A lancet, laser, keratolytic (e.g. salicylic acid solution), sand paper or other means may be used to disturb the stratum corneum to increase permeation before application of the device according to the invention.
The materials used in constructing the components of the invention will be selected to be compatible with the various reactants and products.
The present invention overcomes the shortcomings of transdermal technology by allowing larger molecular substances to be administered in a controlled manner to a patient'"'"'s body. The present invention also overcomes the shortcomings of the "pump systems" by allowing for an inexpensive, reliable, and portable drug infusion device.
The invention is further explained by the following illustrative
A device is built as depicted in FIGS. 1-4. The apparatus, generally 120, has a housing 124 comprised of various hereinafter described parts. The housing 124 contains two annular fluid reservoirs defined by two compartments 154, 156. The first compartment 154 contains the fluid (e.g. an analgesic) to be delivered. The second compartment is to receive a driving gas (e.g. oxygen) produced by an electrochemical gas generating cell or pump 126. In the depicted device, the second compartment contains a pressure relief valve 127 for use in case of over pressure. In the depicted embodiment, the pump 126 is powered by a battery 138. The compartments 154, 156 are separated by an insoluble, water impermeable, polymeric (e.g. polyethylene) flexible membrane 158. The sum of the volumes of the two compartments 154, 156 remains generally constant.
In the device of FIGS. 1-4, the first compartment 154 is fluidically associated with a discharge conduit 125. Conversely, the second compartment 156 is associated with an input conduit 122 for receiving driving gas produced by the electrochemical gas generating cell 126.
The cell 126 and the battery 138 are associated with one another as a module 140 by means of a container 142 made of a conductive metal. Included within the depicted module 140 are the cell 126, the battery 138, an electrical insulating member 144, and a conduit 146 for fluidically connecting a needle 150 or other delivery means with the discharge conduit 125. The module 140 is sealed from the atmosphere by 0-rings (e.g. five or six) contained within compartments 147A-D aligned in the interior of the device 120.
One part of the housing 124 is a threaded female member 152. This threaded female member 152 cooperatively interacts with an electrically conductive, threaded male member 160. This threaded male member 160 has a knob 162. When the knob 162 is turned clockwise, it moves the threaded male member 160 down the threaded female member 152 driving the module 140 into a position wherein the conduit 146 fluidically interacts with the discharge conduit 125, and any gas produced by the cell 126 is in fluid communication with the input conduit 122 (compare FIG. 3 with FIG. 4). Upon actuation, the threaded male member 160 comes into physical contact with the battery 138. This completes the electrical circuit between the battery and metal container 142, and gas generation starts.
As depicted in FIGS. 3 & 4, the housing 124 also includes an indentation 164 for receipt of a layer 166 for containing compounds such as adhesives, antiseptics, and local anesthetics. Adhesives for use with skin are preferably hypoallergenic substances such as silicone adhesive formulations known to those of skill in the art. The layer 166 includes compounds such as antiseptics (e.g. ethanol) and a local anesthetics (e.g. benzocaine). In one embodiment (not shown) the needle 150, upon actuation of the male threaded member 160 actually pierces the layer 166 containing local anesthetic and antiseptic.
A cover off the adhesive layer 166 is peeled of the device of EXAMPLE I. The device has a potent anti-coagulating compound (e.g. TPA from Genentech) contained within the reservoir 154 and normal saline contained within the conduit 146 associated with the needle 150 and within the lumen of the needle 150. The device is adhered to a subject'"'"'s skin. The antiseptic and local anesthetic associated with the adhesive layer act to disinfect and anesthetize the skin. The knob 162 is turned clockwise in the housing 152, thereby completing an electrical connection between the battery 138 and the cell 126, while, at the same time, aligning the input 122 and discharge conduits 125 with the corresponding members 146 of the module 140. The module'"'"'s movement downward within the device also causes the end of the needle 150 to protrude through the level of the adhesive layer 166 and into and through the skin a length sufficient to administer a compound subcutaneously.
Upon electrification, the cell 126 begins generating oxygen. This oxygen gas builds up within the module 140 and passes out into the input conduit 122 and, therethrough, to the second compartment 156. The second compartment 156 fills with oxygen (FIG. 4). Since the sum of the volumes of the two compartments 154, 156 remains constant, the membrane 158 constricts about the first compartment 154, expelling fluid through the discharge conduit 125 and into the conduit 146 associated with the needle 150. Normal saline (or a similar fluid), previously placed in the conduit 146 is thus dispensed from the needle 150, followed by fluid previously contained within the first compartment 154. Since the flow of oxygen into the second compartment 156 is constant, a constant flow of fluid is dispensed from the device 120 and maintained.
A device 168 according to FIGS. 6 & 7 is built. The device 168 has two reservoirs 170, 172, one containing a first liquid containing a first compound, and a second containing a second liquid containing a second compound, especially a compound not chemically compatible with the first compound on a long term basis. Alternatively, the second compound can contain a transdermal permeation enhancer. Each compound containing compartment has its own discharge conduit 174, 176 associated therewith. Preferably, the liquids are of the same viscosity. If however the liquids are of varying viscosities, the diameter of each conduit can be adjusted accordingly to achieve similar flow rates from the reservoirs. The depicted device lacks a cannula or needle, and the compounds are admixed on an absorbent pad 178 placed atop the subject'"'"'s skin for transdermal application.
The reservoirs are contained within a housing 180. The housing 180 also contains a driving battery 182, electronically associated (via resistor 184) with a gas generating cell 186. The gas generating cell 186 is in fluid communication with a "balloon" 188. Upon actuation, a switch 190 completes the electronic circuit between the battery 182 and the gas generating cell 186, causing the cell to generate gas, thus filling the balloon 188. O-rings seal gas inside. As the balloon grows larger, it acts to displace the liquid or fluid contained within the reservoirs 170, 172 which are delivered via the reservoirs'"'"'respective conduits 174, 176. An adhesive material 179 may be affixed to an area abutting the outer circumference of the housing 180.
Before the transdermal device is adhered to the subject'"'"'s skin, a lancet 194 (FIG. 8) having a point 195 of a length to pierce the stratum corneum, but not the epidermis, or other means (e.g. tape, multi-pronged member, or sand paper) is used to destabilize the stratum corneum under the area of the skin where the transdermal pad 178 is to be applied.
An embodiment 196 such as that depicted in FIG. 9 is built. This device 196 has a first fluid chamber 198 and a second fluid chamber 200. The device 196 has batteries 202A, 202B, gas generating cells 204A, 204B, a deformable membrane or bellows 206A, 206B, and a valve 208 made of an elastomeric material. This device 196 may be used to deliver two fluids at different rates through a single outlet 210, and thus has added utility when the combination of the two fluids has a more limited shelf-life than the fluids stored separately. The outlet 210 may be connected to a needle or a sponge (not shown) depending on the delivery required.
Upon actuation, the gas generating cells 204A, 204B begin generating gas which moves the bellows 206A, 206B compressing the fluid chambers 198, 200. Fluid contained within the chambers 198, 200 is forced out ports 212, 214 associated with the chambers and outlets on the valve 208. The check valve is cylindrical and is made of elastic material. The outside diameter is slightly larger than the hole into which it fits. The thin sections on the top and bottom allow the elastomeric material to deform by the pressure in the fluid chambers allowing the fluid to pass by the valve. The thick section in the center will not deflect, preventing fluid from one chamber from entering into the other chamber. Normally, the valve is closed. Valve flexibility, port size (in conjunction with chamber size), current flow, and gas generation speed may all be used, singly or in combination to alter the flow of fluid from the reservoirs.
A device is built as depicted in FIG. 10. This device includes a battery 216 in association with a gas generating cell 218. Underneath the cells 216, 218 is a fluid containing reservoir 220. Associated with the fluid containing reservoir 220 is a needle 222. The needle is of such a length that it pierces the skin of a subject (e.g. to a subcutaneous level) when frame 224 is pressed downward by a user, and the needle protrudes from the housing 226 (not shown). Springs 228, 230 act to separate the frame 224 from the housing 226, opening the electrical circuit.
The reservoir 220 is associated in fluid tight communication with the chamber containing the cells 216, 218 via flexible membrane 234. Upon actuation (e.g. by pressing down the frame with respect to the housing), the electrical circuit is completed, and the cells 216, 218 begin generating a driving gas which deforms the membrane 234, thus driving fluid out of the reservoir 220, through the needle 222 and delivering the fluid to the patient.
Although the device is shown as only being actuated when the frame is held down, in alternative embodiments, it can be made as a retractable ball point pen mechanism (e.g. semi-permanent) or as a permanently protruding mechanism (not shown).
A device 235 as depicted in FIGS. 11 and 12 (shown twice its actual size) is made. In general, the device 235 has two components, a drug package portion 236 (surrounded by a dotted line) and the remainder of the device which comprises an associated control unit for the drug package. In the depicted embodiment, the drug package 236 is integrally formed with the control unit so that the control unit may be disposable. In an alternative embodiment (not shown), the drug chamber is detachably associated with the remainder of the control unit, so that the control unit may be re-used.
The drug package includes two "clamshell" halves 238, 240 joined together (e.g. by a suitable adhesive) between which is pinched a flexible, gas impermeable membrane 242. The membrane 242 separates a driving gas chamber 244 from a chamber 246 for containing a liquid to be delivered. The dispensing liquid chamber 246 is in fluid communication with a septum 248 for receiving the liquid to be delivered. The septum 248 is connected to a conduit 250 which extends into the dispensing liquid chamber 246 for receiving a needle from a needle-bearing syringe filled with dispensing liquid (not shown). The septum 248 acts as a barrier between the conduit 250 and the atmosphere. The dispensing liquid chamber 246 is also associated with a dispensing needle 254.
The interior 256 of the dispensing needle 254 is in fluid communication with the dispensing liquid chamber 246 so that the liquid may be delivered from the device through the lumen 256 of the needle 254.
An adhesive layer 258 adhered to the lower clamshell half 238 surrounds the needle (FIG. 11) for removably attaching the device 235 to the subject'"'"'s skin.
The upper clamshell half 240 is formed of flexible material so that the device 235 may be "primed" by pushing in on that clamshell half 240 thus driving dispensing liquid into the dispensing needle 254. Alternatively, a mechanical screw or other device can be used to apply pressure to the outside of the packet (turned upside down) until all gas is expelled from the chamber containing the liquid to be delivered. Associated with the upper clamshell half 240 is a galvanic-type gas generating cell 260 in such a manner (e.g. via aperture 262) that exhaust gas from the cell 260 enters the driving gas chamber 244 thus pressurizing it. The galvanic cell is electronically associated with a control circuit 264.
The device 235 works essentially like the other devices described herein. A switch actuates the electronic control circuit 264, starting gas generation from the cell 260, which exhausts into the driving gas chamber 244, thus deforming the membrane 242 which separates the two chambers 244, 246 compressing the liquid containing chamber 246 forcing liquid out of the needle 254. The delivery rate from the delivery needle 254 is relatively slow (e.g. from about 0.1 to about 2.0 cc per hour) and the volume of the chamber 246 containing the liquid to be delivered is greater than 0.5 cc (e.g. from 5 to 200 cc).
A device 266 is built as depicted in FIGS. 13 and 14. The device is similar to that of the preceding EXAMPLE, however instead of using a dispensing needle to deliver the liquid, the device 266 uses a transdermal patch 268 comprised of a small piece of sponge foam. A port 270 extends between the liquid chamber 246 and the sponge foam 268.
Although the invention has been described with regard to certain preferred embodiments, the scope of the invention is to be defined by the claims. For example, besides being useful in medical applications, the device for controlled fluid delivery may be used in dispensing fragrances, insecticides, lubricants, or anti-corrosive agents.